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ABSTRACT 
This dissertation concentrates on the introduction of Predictive Adaptive Radiation Therapy 
(PART) as a potential method to improve cancer treatment. PART is a novel technique that 
utilizes volumetric image-guided radiation therapy treatment (IGRT) data to actively predict the 
tumor response to therapy and estimate clinical outcomes during the course of treatment.   To 
implement PART, a patient database containing IGRT image data for 40 lesions obtained from 
patients who were imaged and treated with helical tomotherapy was constructed.  The data was 
then modeled using locally weighted regression.  This model predicts future tumor volumes and 
masses and the associated confidence intervals based on limited observations during the first two 
weeks of treatment.  All predictions were made using only 8 days worth of observations from 
early in the treatment and were all bound by a 95% confidence interval.  Since the predictions 
were accurate with quantified uncertainty, they could eventually be used to optimize and adapt 
treatment accordingly, hence the term PART (Predictive Adaptive Radiation Therapy). 
 
A challenge in implementing PART in a clinical setting is the increased quality assurance that it 
will demand.  To help ease this burden, a technique was developed to automatically evaluate 
helical tomotherapy treatments during delivery using exit detector data.  This technique uses an 
auto-associative kernel regression (AAKR) model to detect errors in tomotherapy delivery.  This 
modeling scheme is especially suited for the problem of monitoring the fluence values found in 
the exit detector data because it is able to learn the complex detector data relationships.  Several 
AAKR models were tested using tomotherapy detector data from deliveries that had intentionally 
inserted errors and different attenuations from the sinograms that were used to develop the 
model.  The model proved to be robust and could predict the correct “error-free” values for a 
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projection in which the opening time of a single MLC leaf had been decreased by 10%.  The 
model also was able to determine machine output errors.  The automation of this technique 
should significantly ease the QA burden that accompanies adaptive therapy, and will help to 
make the implementation of PART more feasible. 
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 1. INTRODUCTION 
Radiation therapy or radiotherapy is the use of high energy radiation to control or kill cancer 
cells and shrink tumors.  It is the most commonly used method for treating cancer and is 
recommended for many types of cancer [Khan 2003].  Recent years have seen rapid advances in 
the equipment and delivery techniques associated with radiation therapy.  These advances in 
technology have enabled the use of predictive and prognostic tools that have then been 
successfully employed in other industries.  Specifically, it is now possible to acquire data during 
radiotherapy treatments that are well-suited for the nonparametric modeling scheme.  
Application of these nonparametric models has led to the creation of a new radiotherapy 
treatment paradigm, entitled PART (Predictive Adaptive Radiation Therapy). 
1.1 BACKGROUND AND RESEARCH NEED 
Radiation is a process in which energetic particles or waves travel through a medium or space 
[Hendee et al. 2005].  High dose radiation can be used to treat cancer and other illnesses.  
Radiation can be directly deposited into the patient’s body via radioactive substances 
(brachytherapy) or externally via external beam radiotherapy (EBRT).  In EBRT, the source of 
radiation is outside the patient (such as a radiation beam generated by a linear accelerator) and 
directed to the tumor site.  The high-energy photons or electrons deposit the radiation to the 
region containing the tumor to destroy the cancer cells and, with careful treatment planning, 
ensure the surrounding normal tissues remain unaffected.  In EBRT, no radioactive sources are 
placed inside the patient’s body with EBRT.   
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Although EBRT has been in use for the last 100 years, there have been rapid technological 
advances in EBRT technology over the past 2 decades that have rendered it an even more viable 
treatment option.  A notable improvement was the integration of three-dimensional (3D) 
anatomical information into the radiation therapy planning process.  Another key advancement 
was the development of intensity-modulated radiation therapy (IMRT).  In IMRT, the intensity 
of the beam across different fields of radiation being delivered is modulated so that each field 
may have any number of both low- and high-intensity radiation areas.  This difference in 
intensity enables improved control of the dose distribution, resulting in even better preservation 
of normal tissue.   
 
Another advancement that has helped shape the field of radiation therapy is image-guided 
radiation therapy (IGRT).  Normal structures and tumors can be in entirely different positions 
from one treatment session to the next due to several reasons, including organ filling, tumor 
shrinkage, weight loss, or even subtle movements that occur while breathing.  In IGRT, EBRT or 
more frequently IMRT is carried out with the aid of imaging equipment.  Generally, CT scans or 
X-ray images are obtained in the treatment room just before or during administration of the 
radiation treatment.  These scans are then compared with the reference imaging dataset that was 
acquired at the time of simulation.  This comparison allows adjustments to be made to the 
patient’s position and/or the radiation beams to help ensure the radiation is being delivered as the 
treatment plan intended.  
 
On the whole, all of these advances have improved targeting of tumors by radiation, while 
simultaneously limiting the exposure of healthy tissues to radiation.  It is noteworthy that none of 
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these advancements would have been possible without the parallel advances in computing 
technology.  These sophisticated treatment techniques require extensive data processing, and in 
turn allow more data to be collected.  The collected data provide valuable information regarding 
radiotherapy.  With the correct analysis, the data collected from many IGRT systems can be used 
to determine the patient’s response to treatment and the efficacy of the treatment device.  The 
goal of this work was to find a way to model the data acquired during IGRT treatments to 
improve radiation therapy.  The modeling of the IGRT data has led to the invention of predictive 
adaptive radiation therapy (PART).   
 
Nonparametric models have gained popularity in the last decade due to significant advances in 
statistics, applied mathematics, and computer science.  In nonparametric models, the model 
structure is not previously specified but is instead determined from data.  The specific modeling 
schemes used in this dissertation will be discussed in greater detail in subsequent chapters.  The 
models used in this work were employed with the goal of improving the reliability and efficacy 
of EBRT and aiding the implementation of PART. 
 
1.2 ORIGINAL CONTRIBUTIONS 
In this study, a new approach, PART, that has never been used before in radiation therapy is 
presented.  Although adaptive radiation therapy has been in place for some time, the predictive 
component is original to this work.  A summary of the original contributions to this dissertation 
is presented below. 
 Development and assessment of a non-linear, nonparametric empirical model for 
actively predicting the tumor responses (and the associated confidence interval) 
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while the patient is undergoing radiation therapy.  This model employs a database 
of past tumor responses to predict the response of new patients during treatment 
by using limited observations collected early in the treatment.  Such prediction of 
tumor behavior can potentially be utilized to adjust the treatment course.  
Application of these modeling techniques is the foundation of PART. 
 
 Development and assessment of a non-linear, nonparametric empirical method for 
automatically evaluating exit dosimetry on a helical tomotherapy system using 
auto-associative nonparametric modeling that is robust and has the capability to 
learn complex detector data relationships, even with detector data with a low 
temporal resolution and beam attenuation from the patient.  This technique will 
aid in the implementation of PART by helping to automate the QA process. 
 
1.3 DOCUMENT ORGANIZATION 
This dissertation is organized into 5 major sections.  This chapter is an introduction of the work 
and outlines the original contributions made by the author.  Chapter 2 is a literature survey 
providing an overview of radiation therapy and predictive modeling.  Next, the development and 
assessment of PART for predicting lung tumor response are presented in Chapter 3.  Chapter 4 
discusses auto-associative kernel regression and explains how it can model sinogram data of 
tomotherapy to serve as a prognostic tool and improve quality assurance.  Chapter 5 concludes 
the dissertation and discusses recommendations for future work. 
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2. LITERATURE SURVEY 
This section presents the results of a literature survey that was carried out to describe the need of 
nonparametric modeling in radiation therapy.  The survey gives a more detailed overview of 
radiation therapy.  It discusses some of the advances in radiation oncology that were mentioned 
in the previous section with greater focus on the techniques used in this research.  Finally, the 
history of nonparametric models is presented with a discussion of how these models are currently 
used in the field of radiation therapy. 
2.1 RADIATION THERAPY 
The primary goal of radiation therapy is to permanently damage the DNA of cancer cells, 
thereby resulting in cell death.  Radiation was applied in medicine soon after the discovery of X-
rays by Roentgen in 1895 [Williams 1902].  However, a considerable limitation at the time was 
the absence of high-energy beams that could adequately treat deep-seated tumors.  However, in 
the late 1950s to the early 1960s, Co-60 units and megavoltage linear accelerators began to be 
used to noninvasively irradiate non-superficial lesions  [Suntharalingam et al. 2005].  Today, 
medical linear accelerators (commonly called linacs) use microwave technology to accelerate 
electrons in a wave guide.  These electrons can be collimated and used to treat shallow lesions.  
In the case of deeper tumors, the electrons collide with a target metal having high atomic number 
(usually tungsten).  The collisions elicit high-energy X-rays from the target, which then serves as 
the source of radiation.  Karzmark’s [1981] primer offers an in-depth description on the history 
and operating principles of linacs.  Figure 1 shows the schematic of a present day linac (Images 
courtesy of Elekta).  
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Figure 1  Diagram of a Linear Accelerator 
 
For typical EBRT treatments, the patient is placed on a treatment couch while a mega-voltage X-
ray beam is generated and emitted from the gantry head of the linac.  The gantry can rotate 
isocentrically to treat the tumor from various angles.  The prescription dose is usually divided 
into multiple fractions and delivered over a period of weeks rather than completed in a single 
undivided fraction.  Dose fractionation is carried out in order to preserve normal tissue while 
allowing cell cycle redistribution and reoxygenation of the tumor cells for more effective tumor 
cell killing [Hall 2006].  The greatest challenge associated with radiotherapy is to minimize 
detrimental effects of radiation on the surrounding healthy tissue whilst simultaneously 
maximizing the degree of tumor destruction.  The side effects from overdosing healthy tissue 
with radiation can be as severe as the effect of the tumor itself; conversely, reduced doses of 
irradiation may allow tumor regrowth.  Many radiation delivery techniques have been proposed 
and used over the years, all with the aim to improve preservation of normal tissue and dose 
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conformity.  The following sections describe some of the different techniques of radiation 
therapy, with emphasis on those pertinent to this research. 
2.1.2  THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY  
Three-dimensional conformal radiation therapy (3D-CRT) is a sophisticated type of EBRT.  In 
3D-CRT, 3D images of the patient are acquired before the start of treatment.  These images are 
used to delineate the tumor and surrounding normal structures.  Generally, the physician 
contours and prescribes a dose to the planning target volume (PTV).  The PTV is an expansion of 
the gross tumor volume (GTV), which is defined as the gross palpable or visible extent of the 
disease, and the clinical target volume (CTV), which contains the GTV plus an expansion to 
account for subclinical microscopic malignant disease [ICRU Report 50, 1978].  The PTV 
should account for all the possible geometrical variations and inaccuracies to ensure that the 
prescribed dose is actually absorbed in the CTV [ICRU Report 50, 1978].  From the 3D images, 
a computerized treatment planning system (TPS) renders a three-dimensional model of the 
treatment field and calculates how the dose will be deposited in the patient.  The treatment 
planning system determines the shape of each treatment beam according to the projected target 
shape at a given gantry angle. 
 
During delivery of the dose in 3D-CRT, the beam intensity of each treatment field is uniform, and 
only the beam aperture is shaped to match the projection of the target.  The beam aperture can be 
modified using shielding blocks or a multi-leaf collimator (MLC) [Takahashi 1965].  The MLC 
is a device with movable leaves or shields of a material with a high atomic number; the device is 
attached to the gantry head [Brewster et al. 1995].  The leaves move independently to block 
some fraction of the radiation beam.  Typical MLCs have 20–80 leaves, arranged in pairs.  
Computer controls are used to position many narrow, closely abutting leaves to generate a field 
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of arbitrary shape.  Figure 2 illustrates this principle in a picture of an Elekta MLC device.  
Galvin et al. [1995] outlined the different design features of several MLC’s and discuss how they 
are used as a substitute for alloy block field shaping.  Since the early 1990s, 3D-CRT has been 
considered the standard of care in radiation therapy treatments for most tumors [Feng 2007].  
However now that most linac designs employ MLCs, intensity modulated radiation therapy is 
becoming a more common delivery method. 
 
Figure 2  Elekta MLC and microleaf MLC 
2.1.3  INTENSITY-MODULATED RADIATION THERAPY  
Intensity-modulated radiation therapy (IMRT) is a relatively recent advance in radiation delivery.  
Unlike the 3D conformal technique, the beam intensity of IMRT varies across the treatment field 
depending on the shape of the desired target region.  IMRT treatments aim to deliver an optimal 
dose to the target by modulating each incident treatment beam into smaller segments [Ezzell et 
al. 2003].  Rather than being treated with a large uniform beam, the patient is treated with many 
small pencil beams (referred to as beamlets), each of which can have a different intensity.  The 
intensity of each beam is modulated by manipulating the MLC leaves moving into and out of the 
treatment field or with externally mounted 3-dimension compensators.  By modulating the beam, 
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each beam delivers radiation with varying fluence.  Thus, IMRT can deliver radiation with more 
degrees of freedom than 3D conformal therapy.  
 
In IMRT, the treatment planning process involves selecting beam geometry and beamlet 
intensities to produce the best dose distribution.  Since there are many possible beam geometries, 
beamlets, and range of beamlet intensities, there is an infinite number of possible treatment 
plans, and consistently and efficiently generating high-quality treatment plans is beyond human 
capability.  Palta and Mackie [2003] explain how it is necessary to design and implement 
computer-based optimized decision support systems that can construct high-quality IMRT 
treatment plans in a short period of time.  The increased complexity of IMRT planning and 
delivery gives rise to many safety concerns.  The American Society for Radiation Oncology 
(ASTRO) Board of Directors recently commissioned a series of white papers addressing patient 
safety, with one specifically concentrating on IMRT [Moran et al. 2011].  This report, entitled 
“Safety considerations for IMRT: Executive summary,” provides considerable background 
information and a detailed literature survey of IMRT.  It also broadly addresses the safe delivery 
of IMRT, with a primary focus on recommendations for human error prevention and methods to 
reduce the occurrence of errors or machine malfunctions.   
 
Safety is paramount in IMRT, especially because the segmentation of an individual treatment 
field leads to complex patterns of intensity distributions as well as non-trivial MU settings. Thus, 
it is recommended that patient specific QA be performed before the patient starts treatment.    
Generally, this QA process begins by using the treatment planning computer to recompute the 
individual delivery pattern onto a phantom.  The treatment is delivered to the phantom and 
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analysis is done to verify that the delivered dose distributions agree to those that were produced 
by the treatment planning computer. Most phantoms designed for IMRT QA have a space to 
insert radiographic film (Figure 3).   The film is calibrated so that its density corresponds to dose, 
allowing for comparison between planned and measured dose.  Additionally some phantoms 
have a slot for an ion chamber so that absolute dose measurements can be taken. There are also 
surrogates for the complete set of measurements with film phantom/ion chamber. Examples of 
these surrogates include electronic portal imaging devices or electronic 2-D measuring tools, 
such as diode arrays or ion chamber arrays. AAPM Task Group 120 “Dosimetry tools and 
techniques for IMRT” provides a comprehensive overview of how dosimeters, phantoms, and 
dose distribution analysis techniques should be used to support the commissioning and quality 
assurance requirements of an IMRT [Ezzell et al. 2009].  Regardless of the device or method, it 
is necessary that every clinic that uses IMRT have a patient specific QA program which requires 
that the deliverability of the IMRT plan is validated before the patient undergoes treatment.   
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Figure 3  IMRT Film Phantom w/ Ion chamber (Left) and IMRT Film Analysis comparing Calculated vs. Measured 
Dose. 
 
Although IMRT is much more time and resource intensive than conventional radiotherapy, it’s 
many clinical benefits seem to be worth the extra effort.  For many types of cancer, such as 
prostate cancer and head and neck cancer, the use of intensity modulation allows more 
concentrated treatment of the tumor volume, while limiting the radiation dose to adjacent healthy 
tissue.  Veldeman et al. [2008] compared IMRT and non-IMRT treatments for different tumor 
sites.  Since IMRT also facilitates directing higher radiation doses on regions within the tumor 
while sparing normal tissue, many physicians are treating tumors to a higher dose.  However, this 
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dose escalation requires greater accuracy in patient positioning.  The need for improved 
positioning accuracy encouraged the introduction of image-guided radiation therapy (IGRT). 
2.1.4  IMAGE-GUIDED RADIATION THERAPY  
IGRT is the use of frequent imaging during a course of radiation treatment to direct the radiation 
towards the target site.  In IGRT, an image is acquired before treatment and compared to a 
reference image for dose planning.  The results of this comparison are used to adjust the tumor 
position by isocenter correction.  It is important to note the distinction of IGRT from the use of 
imaging to enhance target and organ delineation in the planning of radiation therapy.  Basically, 
IGRT systems employ linear accelerators (or other radiation delivery devices) equipped with 
imaging technology that can image the tumor or internal anatomy in real-time before or even 
during the radiation therapy.  Currently, various advanced imaging techniques are available for 
IGRT, such as transabdominal ultrasound [Langen et al. 2003, Fuss et al. 2004], implanted 
markers with kilovoltage (kV) or megavoltage (MV) X-ray images, kV computed tomography 
(kVCT) onrail [Wong et al. 2005], kV or MV cone beam computed tomography (CBCT) [Jaffray 
et al. 2002], and helical mega voltage CT (MVCT) [Kupelian et al. 2006].  
Figure 4 illustrates a type of IGRT with a kV CBCT of a lung patient obtained using the patient 
in the treatment position directly before the beam was turned on.  The CBCT is overlaid onto the 
reference simulation CT dataset.  A checkerboard display is used where the darker image is the 
CBCT and the lighter image is the reference CT.  This overlay helps clinicians to visualize 
whether or not the treatment volume is off target from the planned target and make the necessary 
adjustments to ensure accurate treatment. 
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Figure 4  kV CBCT images matched to the reference images to setup the patient to the simulation position 
Xing et al. [2006] summarized the recent advancements in IGRT and discussed various practical 
issues related to the implementation of the new imaging techniques available to radiation 
oncology community.  The key benefit of IGRT technology is that it allows physicians to greatly 
reduce the added margin since the tumor location can be visualized moments before the 
treatment is administered.  This is an important feature for the following 2 reasons: 
1) A reduced margin translates into less normal tissue within the radiation field, suggesting 
that there is a significant reduction in the risk of damage to the immediately adjacent 
structures.  
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2) Reducing the treated area also allows increase in the radiation dose that can be safely 
administered.  Again, the same rules that governed a century ago continue to apply: the 
higher the dose, the greater will be the chance for cure. 
In summary, IGRT allows verification of the target location at the time of treatment.  It permits 
the physician to tailor patient-specific PTV margins.  With IGRT, field margin and treatment 
dose can be routinely customized to each individual patient to achieve a safe dose escalation. 
Finally, it facilitates adaptation to on-treatment changes by correcting or moderating setup 
changes, assessing anatomical changes, or in some cases, re-planning.  In other words, adaptive 
therapy becomes possible.   
2.1.5 Adaptive Therapy 
Yan et al. [1997] describe adaptive radiation therapy as “a closed-loop radiation treatment 
process where the treatment plan can be modified using a systematic feedback of 
measurements.” The idea of adaptive radiation therapy is to systematically monitor treatment 
changes and incorporate these variations to re-optimize the treatment plan during the course of 
treatment.  There are many Adaptive Radiation Therapy (ART) techniques that have been 
developed to exploit the additional information provided by the imaging devices [Martinez et al., 
2000; Keller et al., 2003; Ferris and Voelker, 2004; Harris, 2009].   
There are two approaches to ART – on-line or offline.  In on-line ART, the treatment is adapted 
to variations during the delivery of a fraction, while the patient is lying on the table.  In contrast, 
off-line ART waits until after the treatment is complete and then retrospectively uses the 
measurements from imaging devices to make adjustments.  Since in offline ART, the imaging 
data does not become available until after the delivery of a fraction, it allows for a more thorough 
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and careful analysis. Another advantage of off-line ART is that it does not affect the duration of 
a fraction, and therefore the patient throughput, since the treatment is not modified during the 
delivery. In the remainder of this dissertation, whenever the term ART is used, it can be assumed 
to mean off-line ART.  The next section describes tomotherapy, an IGRT treatment device 
featured prominently in this dissertation, with imaging capabilities well-suited for ART. 
2.1.6 HELICAL TOMOTHERAPY 
The Tomotherapy Hi-Art System is an IGRT delivery system developed by TomoTherapy Inc. in 
Madison, WI.  The technology was pioneered mainly by professor Thomas Mackie, PhD, 
students Timothy Holmes and Stewart Swerdloff, and researcher Paul Reckwerdt [Mackie et al. 
1993].  The first commercial version, termed the HI-ART
 
2, was clinically implemented at the 
Thompson Cancer Survival Center, Knoxville, TN, USA, in July 2003 [Mackie 2006].  The 
AAPM recently published Task Group 48, “QA for helical tomotherapy” that offers a 
comprehensive review of the tomotherapy technology and provides recommendations for the 
quality assurance that should be performed when using this modality [Langen et al. 2010]. 
 
 The name “Tomotherapy” literally means slice therapy [Mackie et al. 1995].  The name signifies 
that the radiation is delivered “slice by slice” because of the helical nature of the system.  The 
tomotherapy unit essentially consists of a linear accelerator mounted on a CT slip-ring gantry.  
The patient lies on the treatment couch, which moves into the gantry as a narrow 6 MV radiation 
beam continuously rotates around the patient.  The couch moving at the same time the gantry is 
rotating, resulting in a helical pattern radiation beam around the patient, which targets tumors 
with optimal levels of radiation.  This method offers the advantage of having a radiation 
treatment beam projected into the tumor continuously as it rotates rather than having a limited 
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number of fixed beams, each providing only a fraction of the dose necessary to irradiate the 
tumor.  Figure 5 presents a diagram illustrating the tomotherapy system.  
 
Figure 5  Basic schematic of the tomotherapy Hi-Art System 
 
A unique aspect of helical tomotherapy is that radiation is delivered with a fan beam rather than 
a traditional cone beam.  The thickness of the radiation field from this fan beam is reduced as the 
jaw setting is selected as 1.0, 2.5, or 5 cm during the planning stage.  However, the width of the 
beam is maintained up to a maximum of 40 cm.  The system also has a beam stopper on the 
rotating gantry opposite the accelerator.  The beam stopper consists of 13-cm-thick lead slabs 
that act as a counterweight and primary beam attenuator [Ramsey et al. 2006]. 
 
IMRT delivery is achieved by moving the 64 individual leaves into and out of the fan beam.  The 
MLC leaves are made of tungsten and have a width of 6.25 mm at the isocenter.  The MLCs are 
pneumatically driven and considered binary.  The term “binary” represents the 2 discrete 
positions allowed for the collimator leaves: open or close.  The length of time that a leaf is open 
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is proportional to the intensity of radiation allowed through at a particular portion of the beam.  
The MLC leaves are designed with an interlocking tongue-and-groove design to minimize 
leakage when adjacent leaves are closed.   
 
Other than the jaw setting, the pitch and modulation factor are other factors impacting the 
tomotherapy delivery that must be selected during the planning process.  The pitch represents the 
distance that the couch moves into the gantry bore for each rotation of the gantry.  For example, 
a pitch value of 1/3 will result in the couch moving into the bore at 1 beam width for every 3 
rotations.  A smaller pitch value would allow for steeper dose gradients but also result in longer 
treatment times.  The modulation factor represents the ratio of maximum leaf opening time to the 
mean leaf opening time of all MLC leaves open in a given projection [Kissick et al. 2005].  As 
opposed to the pitch value, increasing the modulation factor will result in longer treatment times 
but aid in reducing the dose to unspecified tissue and sensitive structures. 
 
Tomotherapy employs an arc-shaped CT xenon detector to acquire the pretreatment MVCT 
images.  The high quantum efficiency of the detector results in improved image quality 
[Hinderer 2003].  The images obtained before the treatment are used to correct for the positional 
uncertainties associated with setup error and inter-fraction organ motion.  The position of the 
target volume relative to the treatment isocenter can then be corrected by moving the patient with 
appropriate offsets.   
 
The tomotherapy detector consists of 738 detector cells.  Each cell is comprised of 2 gas cavities 
divided by a thin tungsten septal plate.  The distance between the 2 plates, 0.32 mm, defines the 
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size of a single gas cavity; the thickness of the plates is also 0.32 mm.  The septal plates are 2.54 
cm long in the beam direction.  A potential of 1300 V is applied across every odd plate, and the 
even plates function as charge-collecting electrodes for the charge produced in the gas cavities.  
The gas cavities are filled with xenon gas under high pressure.  The front face of the detector is 
placed 129.2 cm away from the photon source.  Since the radius of the detector arc measures 
only 103.6 cm, the geometrical center of the detector is slightly off-focus with the source.  The 
detector focus point is in front of the detector at a distance of 25.6 cm away from the photon 
source, directed towards the isocenter.  In addition to the xenon detector array, there are 3 
ionization chambers located between the rotating X-ray target and the multi-leaf collimator.  
These sealed ionization chambers measure the machine output prior to attenuation by the patient 
and store the data in a binary file called a sinogram.  This is a binary file that contains data for 
each projection.  There are several types of sinograms in tomotherapy, such as imaging 
sinograms derived from detector data or control sinograms that contain fluence or MLC data for 
each projection [Langen et al. 2010].  The sinograms referenced in this work are those collected 
by the detector array during treatment.  These sinograms record the radiation exiting the multi-
leaf collimator and passing through the patient during the treatment.  Chapter 4 describes these 
sinograms in greater detail, as they are an integral part of this research. 
 
Overall, this work hinges on the tomotherapy detector array.  Chapters 3 and 4 describe how the 
information obtained by the detector (both in the form of the MVCT images and in the treatment 
sinograms) contain data that have not been previously used to advance radiation therapy 
treatment.  Both the daily MVCT images and the treatment sinograms can be fed into predictive 
models to determine information about both patient response and machine performance.  Chapter 
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3 discusses how information thus obtained from the daily MVCT scans taken before treatment 
initiation can be used to adjust the patient as well as measure the tumor response.  Chapter 4 will 
detail the applications of empirical nonparametric models for detecting errors in the compressed 
tomotherapy sinogram data.  Both these applications illustrate how predictive nonparametric 
models can be effectively applied to radiotherapy data.  These types of models are being widely 
adopted in other industries, particularly finance- and engineering-driven fields requiring the 
estimation of performance levels of a system.  However, although these models are specifically 
suited to resolve many of the problems in radiation therapy, they have not yet been widely 
applied in this field.  The next section explains this concept with a brief overview of 
nonparametric regression modeling.   
2.2 NONPARAMETRIC MODELING 
The definition of modeling may vary depending on the application, but the basic concept remains 
the same.  As noted by Atkeson et al. [1997], modeling can be defined as “the process of solving 
physical problems by appropriate simplification of reality.”  Similarly, Sorakin [2005] defines a 
model “as a description of a system designed to help an observer to understand how it works and 
to predict its behavior.”  From this definition, models are then categorized as either mechanistic 
or empirical.  It is important to note that there are many ways models can be classified, and few 
statisticians or researchers agree on the classes or subclasses that fall under the general and very 
broad term of “modeling.”  However, Figure 6 presents the modeling hierarchy that is adopted in 
this work. 
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Figure 6  Modeling hierarchy explained 
 
Mechanistic models have a structure that explicitly represents an understanding of biological, 
chemical, and/or physical processes.  A huge benefit of mechanistic models is that they do not 
require much data for development, and are therefore not subject to peculiarities in data.  
However, because they require a fundamental understanding of the physics and chemistry 
governing the process, they can often be very time consuming and occasionally impossible to 
construct in cases where the interactions between the process variables have not been fully 
understood.  Velten [2009] offers a thorough primer on mechanistic modeling that highlights 
their many advantages and applications, especially in biology and thermodynamics.  In contrast 
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to mechanistic models, empirical models are solely based on the observations found in the 
collected data.  Empirical models are not derived from assumptions concerning the relationship 
between variables and are not based on physical principles.  Empirical modeling has become a 
widely used analytical tool in almost all scientific fields.  It has gained popularity in recent years, 
most likely, due to the fact that this type of modeling can still produce accurate and reliable 
results without requiring intimate knowledge of the underlying (and usually very complicated) 
first-principals which govern the system being modeled.  This work focuses on previously 
mentioned empirical models, specifically nonparametric empirical models.  To understand 
nonparametric empirical modeling, let us first consider parametric models.   
 
There are really only 3 steps to obtain predictions using a parametric model.  First, the 
parameters of the model must be estimated.  The parameters are usually obtained using a set of 
training data, which have known predictor and response variables and are believed to be un-
faulted.  The model parameters are optimized to best fit the training data and the data are 
discarded.  The state is then estimated.  Finally, the given observations are plugged into the 
model to predict for the unknown response variable or the future results.   
 
To illustrate this, consider the following polynomial model: 
2
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In order to completely define this model for a given set of training observations, the polynomial 
coefficients bi are optimized to minimize an objective function, usually the sum of the squared 
error (SSE).  Once the optimal polynomial coefficients have been estimated, the model is 
completely specified by the equation and the estimated coefficients.  The data used to develop 
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the model are no longer needed and are not retained.  Therefore, a parametric model may be 
roughly defined as a model that may be completely specified by a set of parameters and a 
functional relationship for applying these parameters to new data in order to estimate the 
response. 
 
In contrast, a nonparametric model stores historical data exemplars in memory and processes 
them when a new query is made.  For instance, rather than modeling a whole input space with a 
parametric model such as a neural network or linear regression, local nonparametric techniques 
may be used to construct a local model in the immediate region of the query.  These models are 
constructed “on the fly” and not beforehand.  When the query is made, the algorithm locates 
historical exemplars in its vicinity and performs a weighted regression with nearby observations.  
The observations are weighted with respect to their proximity to the query point.  In order to 
construct a robust local model, one must define a distance function to measure what is 
considered local to the query, implement locally weighted regression, and in some cases consider 
additional regularization techniques.  The clear advantage of a nonparametric technique is that 
the model structure is not specified apriori but is instead determined from data.  Rather than 
determining parameters (such as the regression coefficients in linear regression or weights in 
biases in neural networks) and then discarding the historical data, nonparametric models retain 
all data and use them in the predictions.  Nonparametric models decide which observations in the 
historical data are representative of the current query, and only use observations which are 
similar to the query to make the prediction.  This local characteristic of nonparametric modeling 
is especially desirable for modeling radiation therapy data.  When undergoing radiation 
treatment, every patient is unique and not all patients will respond the same, meaning global 
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models are not always appropriate.  However, there are definite trends in patient response - 
meaning local models that can dampen out unnecessary data ideal for these applications. The 
term nonparametric is not meant to imply that such models completely lack parameters but that 
the number and nature of the parameters are flexible and not fixed. 
 
There are several factors that need to be considered before deciding whether a parametric or 
nonparametric model should be used.  Both models have clear advantages and disadvantages.  In 
fact, the “no free lunch” theory states that no modeling technique is better than all other 
techniques on all problem types [Wolpert 1997].  Some of the main benefits and drawbacks of 
the different modeling types are listed in Table 1.  Recent work by Hines and Garvey [2006] 
discusses the pros and cons of the different model architectures in greater detail and also 
addresses how one of the main drawbacks of nonparametric modeling can be overcome by using 
robust vector selection methods to improve the quality of trained locally weighted regression 
models. 
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Table 1. Nonparametric vs. parametric models: Key advantages and drawbacks of each model 
NONPARAMETRIC PARAMETRIC 
 
 Can continuously adapt to 
additional operating regions 
because new observations 
may be easily added to the 
memory vector  
 
 Can easily compute 
uncertainty in the model’s 
predictions with 
straightforward analytic 
equations  
   
 Has longer recall time, so 
large models may be difficult 
to implement in real-time 
systems 
 
 Requires time-consuming 
and often unstable updating 
or retraining to expand to 
new operating regions  
 
 The uncertainty of many 
neural network predictions 
cannot be computed without 
using time-consuming Monte 
Carlo techniques 
 
 Has a more straightforward 
architecture and shorter run-
time 
  
Since the early 1990s, computer and software performance has reached a level of sophistication 
compatible with nonparametric modeling.  Computers can now handle large databases of 
memory vectors.  The data used to develop models can be retained without exceeding the 
capacity of the computing system.  As such, many industries have embraced nonparametric 
modeling as a practical tool for prediction, diagnostics, and even prognostics.   
 
Garvey’s PhD dissertation [2007] shows how these nonparametric techniques can be used to 
detect, diagnose, and prognose faults and failures in the hydraulic steering system of a deep oil 
exploration drill.  In finance, similar nonparametric models have been employed for options 
pricing and prediction of high-frequency transactions yield curve data [Lai and Xing 2008].  The 
NUREG-CR 6895 series explains how the nuclear industry is implementing these techniques to 
monitor nuclear plants and extend the required interval for sensor recalibration [Hines et al. 
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2006, 2007].  Similarly, Hubberstone’s dissertation [2010] describes an Adaptive Non-
Parametric Model (ANPM) that has been developed for integrated monitoring, diagnostic, and 
prognostic use on small to medium size nuclear reactors.  In biology, nonparametric models were 
used to quantify the effects of wind direction and wind speed on background NO2 concentrations 
[Donnelly et al. 2011].  There are so many different and varied applications of nonparametric 
modeling in almost every scientific field that it is impractical to highlight more than a few.  As 
Fox [2010] summarizes, “Unthinkable only a few years ago, methods of nonparametric analysis 
and prediction have been rendered practical by advances in statistics and computing, and are now 
a serious alternative to more traditional parametric methods.” 
 
Although predominate in almost every other field, these nonparametric predictive models have 
not been widely used in radiation therapy.  However, their parametric counterparts are used for 
virtually every aspect of radiation therapy treatment planning and delivery.  Most treatment 
planning systems employ empirical models to calculate dose.  Most of these models generalize 
from measurements in specific conditions to predictions of dose in patient.  Korhonen’s 
dissertation [2009] provides a history of the models used by different treatment planning 
systems.  Empirical models are also use to determine EPID response for the purpose of pre-
treatment IMRT dose verification [Khan 2008]. 
 
Furthermore, empirical models are the cornerstone of radiation biology.  These radiobiological 
models are used in modern radiotherapy to evaluate the biological effects of different treatment 
plans or modalities. A radiobiological model typically converts a physical quantity (e.g. absorbed 
dose) to a biological quantity (e.g. cell survival fraction). The two most common empirical 
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models are the Probit and Logit models.  Both models derive mathematical expressions to 
describe by the probability of an effect following radiation dose.  For a more thorough review of 
radiobiological models, the reader is referred to the article entitled “The progress of 
radiobiological models in modern radiotherapy with emphasis on the uncertainty issue” by Wang 
[2010]. 
 
Artificial neural networks, which are parametric models inspired by the structure of biological 
neural networks, have also found wide application in radition therapy.  Leszcynski et al. used an 
artificial neural network (ANN) to evaluate treatment set-up plans.  In that study, an ANN was 
used to accept or reject the radiation dose-volume histogram data for the rectum and urinary 
bladder.  In another study, Kaspari et al. used ANNs to predict desired coefficients for 
polynomials to describe PTVs for glioblastoma multiforme tumors.  These are only two of the 
many examples of how neural networks have been used to improve radiotherapy treatments.  The 
book Intelligent and Adaptive Systems in Medicine presents a more extensive review of neural 
networks in radition therapy [Haas 2008].   
 
In short, parametric models are entirely engrained in radiation therapy.  They are a driving factor 
of the field.  Without the use of parametric models, it would be nearly impossible to treat cancer 
patients with today’s technology.  However, nonparametric models are not as prevalent.  There 
are very few instances in the literature of nonparametric models being used in the field.  Seibert 
[2007] and researchers at Stanford [Li and Xing, 2011] have independently investigated using 
nonparametric techniques to predict the respiratory motion.  Additionally, researchers at 
Washington University have considered using nonparametric methods to learn the complex 
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interactions between observed toxicities and treatment [Bradley and Deasy, 2008].  Bowling 
[2012] also has employed nonparametric models in his work developing Gamma Knife plan 
optimization techniques.  In Bowling’s research, the model is not used for regression, but is 
actually a selection technique.  He uses a nonparametric model to select a set of plans from past 
treatment volume that are similar to the current treatment volume.  The parameters from these 
past plans are then used to initialize the Gamma Knife optimization routines that will be applied 
to the current treatment volume. 
  
Other medical fields that are intertwined with radiation therapy rely on nonparametric 
techniques.  For instance, in medical imaging, nonparametric techniques are used to reconstruct, 
restore, interpolate, optimize, and analyze MRI, PET, and CT scans [Dougherty 2009].  But, 
overall, the examples of nonparametric prediction techniques being used in radiation therapy are 
few and far between.  In general, it seems as if the field of radiation therapy has been reticent in 
implementing these novel methods.  This is unfortunate, as nonparametric techniques can be 
powerful tools that have the potential to be very beneficial.  The next sections will describe how 
these modeling techniques are fundamental in the development and implementation of PART.   
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3.  PREDICTIVE ADAPTIVE RADIATION THERAPY FOR LUNG 
TUMORS 
This chapter describes the basic methodology and results from the locally weighted regression 
lung tumor response model.  The main purpose of this model is to determine if the final change 
in lung tumor mass and volume could be predicted using only information collected by the 
tomotherapy MVCT scans obtained early in the treatment.  The prediction of the final tumor 
mass and volume gives clinicians valuable information about how the tumor is responding to 
radiotherapy treatment and could even lead to the treatment being adapted to account for these 
changes.  Adaptation of the treatment based on the results of the predictive model is a novel 
concept termed Predictive Adapative Radiation Therapy, abbreviated PART. 
 
3. 1  INTRODUCTION TO TUMOR RESPONSE MODELING 
Recent studies have shown that lung tumors can substantially change in size, shape, density, and 
center of movement during the course of radiation therapy [Kupelin et al. 2005; Underberg et al. 
2006].  These changes can be measured with frequent pre-treatment CT imaging, and potentially 
provide information on patient outcomes [Kim et al. 2005].  Although the underlying biological 
mechanisms for tumor responses in individual patients are currently unknown, the response can 
be measured directly during IGRT using soft-tissue imaging.  An assessment of the response to 
therapy during treatment could be used to help direct the patient’s further therapy.  
Unfortunately, patients typically complete with their course of radiation therapy before the tumor 
response is completely analyzed.  Thus, a nonparametric model that employs a database of past 
tumor responses to predict the response for new patients during treatment using limited 
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observations collected early in the treatment.  This forecasting of tumor behavior can potentially 
be utilized to adjust the course of treatment. 
 
Research on image-guided radiation therapy (IGRT) for lung cancers has primarily focused on 
the application of stereotactic body radiation therapy (SBRT) and respiratory management 
techniques [Barnes et al. 2001; Underberg et al. 2005].  The development of CT-based IGRT 
systems has enabled clinicians and lung cancer researchers to volumetrically image internal 
anatomy prior to the delivery of radiation treatment fractions.  These images are primarily used 
to position the patient prior to treatment based on the known position of the tumor and the 
location of the surrounding normal tissues, resulting in potential reduction of the patient setup 
uncertainty and the internal uncertainty of the target position [Scrimger et al. 2003; Kron et al. 
2004]. 
 
In addition to tumor localization, the CT images acquired during IGRT can be used to measure 
and evaluate the response to treatment (Figure 7).  Recent studies have shown that lung tumors 
can substantially change in size, shape, density, and center of movement during the course of 
radiation therapy [Kupelin et al. 2005; Underberg et al. 2006].  These changes can be measured 
with frequent pre-treatment CT imaging, and can potentially provide information on patient 
outcomes [Kim et al. 2005]. 
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Figure 7  Tumor response measured from daily MVCT scans 
 
 
Although the underlying biological mechanisms for tumor responses in individual patients are 
currently unknown, the response can be measured directly during IGRT using soft-tissue 
imaging.  An assessment of the response to therapy during treatment could be used to help direct 
the patient’s further therapy.  Unfortunately, patients typically complete their course of radiation 
before the tumor response is completely analyzed.  
 
In this research, a database of past tumor responses is used to predict the response for new 
patients during treatment using limited observations collected early in the treatment.  This 
forecasting of tumor behavior can potentially be utilized to adjust the course of treatment.  It will 
allow for implementation of ART.  The predictions could also be used in the design of an 
intensity modulated integrated boost to the location of the residual tumor mass [Dirkx et al. 
2004]. 
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3.2 METHODS AND MATERIALS 
3.2.1 TUMOR RESPONSE 
Tumor responses were measured in 37 patients with lung cancer who visited the Thompson 
Cancer Survival Center, London Regional Cancer Centre, and the M. D. Anderson Cancer 
Center Orlando between July 2003 and April 2008 for imaging and treatment with helical 
tomotherapy (HI-ART, TomoTherapy, Inc., Madison, WI).  Several other patients were 
evaluated, but they primarily had medial disease and were not included because their disease 
could not be adequately assessed with MVCT imaging.  A total of 40 lesions were included in 
the study.  Patients were treated with different doses ranging from 2.0–2.5 Gy per fraction 
according to different institutional preferences and protocols.  The total doses and treatment 
fields were implemented at the discretion of the radiation oncologist.  Table A-I (found in 
Appendix A) presents the patient demographics of the study participants.   
 
Megavoltage CT (MVCT) images were acquired prior to the delivery of the lung treatment 
fractions for the 37 patients.  The primary purpose of the MVCT images was to position the 
patients for treatment using an automatic CT-to-CT fusion with the treatment planning CT 
images.  All MVCT images were fused relative to the original treatment planning CT using soft-
tissue anatomic landmark-based fusion.  The tumor volumes (excluding nodal disease) were 
outlined on each MVCT slice using the same window and level settings, which were set to 
enhance the visibility of the lung tumor relative to the surrounding tissue.  Fifteen tumors were 
automatically contoured using Model Based Segmentation of the original tumor volume contours 
from the original treatment plan.  The tumor volumes (and some masses) were calculated by the 
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treatment planning systems based on the defined contours.  The volume and masses were 
recorded against the elapsed day of treatment for all 40 of the tumors in the study. 
 
Additionally, some tumors were re-contoured by different investigators to eliminate inter-
individual variation.  The variation in the contouring between 2 investigators was found to be 
less than 2%.  This low inter-observer variability may be explained by the use of the original 
treatment planning CT contours as a baseline and that 19 out 20 lesions were surrounded almost 
entirely by lung without atelectasis.  Systematic inter-observer errors were present, with one 
investigator consistently contouring smaller tumor volumes.  However, the absolute change in 
tumor volume remained relatively constant regardless of the investigator performing the 
contouring.   
 
The data were relatively complete with a mean of 29 CT image sets per patient.  Missing data 
were replaced using a piecewise cubic spline interpolation function [Press et al. 1992].  All 
replaced data were flagged.  The reconstructed data were then used to develop models to predict 
tumor response, and the models were created using as little of the replaced data as possible. 
3.2.2 TUMOR RESPONSE MODELING 
The tumor responses measured in this study varied greatly from patient to patient.  Figure 8 
shows the change in tumor volume (normalized to the first day of treatment) versus the elapsed 
days of treatment for several tumors.  These tumor responses vary greatly and cannot be modeled 
with a simple linear or low-order polynomial fit.  Rather, a more sophisticated modeling 
technique that can learn complex relationships was required.  The linear weighted regression 
(LWR) model was initially chosen to apply to this data because of its ease of retraining or 
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learning new cases, its ability to determine if the current patient regression is similar to that of 
historical patients, and because analytical techniques are available for uncertainty quantification. 
 
Figure 8  Tumor Response is considerably more varied for a large cohort of patients 
 
Locally weighted regression (LWR) is a nonparametric memory-based modeling technique.  
LWR stores the training data in memory and recalls the relevant data exemplars when a query is 
made.  When a query is processed, the algorithm locates similar training exemplars and performs 
a weighted regression with the nearby observations [Atkeson et al. 1996].  This is different from 
parametric techniques such as neural networks that use an optimization algorithm to iteratively 
calculate the model used to represent a desired input-output relationship.  Parametric training 
procedures are subject to local minima when non-linear techniques are employed, which may 
result in poor models.  Training very complex relationships needed for regression prediction can 
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take days and optimizing the architecture to provide robust results requires extremely 
experienced developers.  Additionally, if new data are acquired, the model must be retrained 
requiring a significant effort.  Nonparametric techniques such as the one proposed in this 
research require no training and new data can easily be added to the historical memory matrix. 
 
LWR is a non-linear, nonparametric extension of linear regression.  It uses a weighted sum of 
squared errors, where the weighting factor considering the distance of the training point from the 
query point is minimized, to give more training points that are closer to the query point.  The 
notation Q(q) is used because the function is optimized around query point q [Fan and Gijbels 
1996]. 
 
     (3-1) 
 
where:  xi are the training points 
q is the query point 
d is a distance function such as the Euclidean distance 
K is a kernel weighting function. 
 
A typical kernel weighting function is the Gaussian kernel with a vector of local bandwidths (h) 
[Wand and Jones 1995]: 
                               ,        (3-2) 
 
with the Euclidean distance given as 
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where: j is the dimension of the vector. 
 
The bandwidth determines the definition of local, i.e., how close a training point needs to be to a 
query point to allow it to influence the prediction.  All the training points within the specified 
bandwidth are used to calculate the prediction for a given query case.  However, the training 
points are entered into the prediction with different weights.  Training points that are nearer to 
the test point are given more importance.  Nevertheless, the bandwidth controls the smoothness 
of the predictions by deciding which neighboring training points will be considered in the 
prediction.  When the bandwidth is small, the local linear estimator interpolates the data points 
and over-parameterizes the unknown function resulting in noisy estimates.  When the bandwidth 
is large, the local linear estimator reduces to the standard parametric linear regression estimate, 
which, with the exception of the cases where the model is correctly specified, under-
parameterizes the regression function, resulting in a large modeling bias.  
  
This study employs local bandwidths, rather than a single global bandwidth.  Local bandwidths 
allows each input variable to have its own unique corresponding bandwidth value; this has been 
shown to improve model performance [Gerard and Schucany 1999].  
 
The following equation solves the above weighted least squares regression equation for the 
optimal estimates of the regression coefficients: 
          (3-4) WYWXWXWXβ TT
1TTˆ
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where W is a diagonal matrix with the diagonals being equal to the square roots of the kernel 
function: 
          (3-5) 
 
Solving the regression equation results in a new estimator: 
            .       (3-6) 
 
Implementing LWR required first selecting the training data (past tumor volume data over the 
number of treatment days elapsed).  Volume data from the 40 historical lesions were used to 
build the initial memory matrix.  This large amount of initial data was sufficient to construct a 
memory matrix capable of producing reliable predictions. 
 
A genetic algorithm (GA) was used to determine the minimum number of test observations that 
yield an accurate prediction.  Since contouring the tumor on MVCT scans is a time-consuming 
process, it is desirable to contour as few scans as possible.  Additionally, an accurate prediction 
is needed as early in the treatment as possible so that there is ample time to modify the treatment 
if needed.  Using a GA proved to be the most efficient and effective way to accomplish this 
result.  
 
A GA starts with a set of solutions represented by chromosomes, called a population, with the 
performance of each solution evaluated by a fitness function [Haupt and Haupt 1998].  In this 
case, each solution contained the different days from which tumor volume data should be 
collected and the vector of local kernel bandwidths.  For example, one solution might evaluate 
)),(( qxdKw iii
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the model using volume data from treatment days 1, 3, 5, 7, 10, and 14 and a vector of 
bandwidths.  Constraints were placed upon the allowed number of observations and how late in 
the treatment these observations could occur.  The fitness function evaluated the leave-one-out 
cross-validation (LOOCV) error of the solution.  To evaluate the LOOCV error, the model was 
run for each lesion using the remaining lesion data as training data, and the average absolute 
error of all predictions was computed.  Obviously, there was a trade-off between the model’s 
accuracy and limiting the number of observations or observations that occurred later in the 
treatment.  However it was found that treatment days 2, 4, 5, 9, 11, 12, 15, and 17 elicited the 
best performance for the smallest number of observations earliest in the treatment.  Since the 
volume data covers several orders of magnitude, the input and output data were mean-centered 
and scaled to unit variance prior to presentation, and the results were scaled back to their original 
units. 
3.2.3 TUMOR RESPONSE MODELING UNCERTAINTY 
Because this technique will eventually be used to make decisions about a patient’s treatment, 
each prediction must be accompanied by a measure of its uncertainty.  A large uncertainty value 
indicates that the prediction is unreliable.  In this study, uncertainty is expressed in terms of a 
confidence interval.  The confidence interval (CI) is a quantification of the agreement of model 
predictions with the system’s true value.  It provides a measure of the uncertainty of a model’s 
expected prediction.  For a confidence level of 1- , the confidence interval was defined by 
Tamhane and Dunlop [2001] as the interval [L, U ] including  (the true system value) with 
a pre-assigned probability of 1-  can be expressed as follows: 
      .        (3-7) 
xf
1UfLP x
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For a confidence level of , the CI may be written as follows in terms of the variance and 
bias: 
     ,       (3-8)  
where:  n is the number of training observations 
   p is the number of variables used to infer y 
 is the t-statistic which approximates the normal distribution for , 
degrees of freedom, and confidence level  
   is the expected model prediction of y. 
 
In this equation, the variance measures the random error of the model’s predictions, while the 
bias measures any systematic error.  For an LWR model, the variance of the estimator is 
calculated using Monte Carlo techniques or with the following analytic equation [Hines 2005]: 
        ,  (3-9) 
where:  , and  
 is the  vector having 1 in the first element and 0 elsewhere 
 is the dimension of the predictor variable set 
 
This definition applies to local linear modeling only for local constant modeling  and 
.  The estimator bias is assumed to be negligible.  This assumption was validated by 
comparing the mean squared error (the average squared error of a model’s predictions and target 
values) to the total uncertainty; the results revealed that the variance was the chief contributing 
component. 
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3.3 RESULTS  
For the 40 easily visualized lesions, the tumor volume response over the treatment course was 
measured using pre-treatment MVCT imaging (Table A-II).  The initial volumes ranged from 
1.9–737.2 cm3, with a mean volume of 102.5 cm3 and a median volume of 32.6 cm3.  The 
predicted final tumor volumes ranged from 0.9–375.8 cm3 with mean and median volumes of 
55.2 and 15.1 cm
3
, respectively.  Tumor regression was correctly predicted in all 40 lesions 
(Figure 9).  Only 15 of the lesions also had mass data, so these predictions are not shown.  The 
mean absolute difference between the true and predicted final volumes was 3.4 cm
3
 (8.4%).  In 
the 2007 publication, the mean absolute error with only 20 lesions was 12%, so the additional 
data did improve model performance.  It is also important to recognize that since not all of the 
patients were treated with the same fractionation scheme, the day that the measurement for the 
predicted final volume will vary between patients (for instance, some patients ended treatment on 
day 35, well others were still receiving treatment at elapsed day 50).  So for the predictions 
shown in the Figure 9, the model was given each lesion’s final volume as its y-training set.    
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Figure 9  LWR Final Volume Predictions for (A) Patients 1–20 and (B) Patients 20–40 
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Figure 10 plots the results of the volume and mass models for 3 typical lesions, with the training 
data (observations used to make the predictions) highlighted by pink circles and the query data 
(data being predicted) shown in red, surrounded by the 95% error bars. 
 
Figure 10  Locally weighted regression volume and mass predictions over the course of treatment for lesions 6, 13, 
and 17. 
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All predictions were based on measured tumor volumes and masses from treatment days 2, 4, 5, 
9, 11, 12, 15, and 17.  This combination of observation days was determined using genetic 
algorithm-based optimization to minimize LOOCV error and the number of observations.  
Although the model is extremely accurate in its predictions made at the end of a patient’s 
treatment, the uncertainty in the shape of the tumor response curve increased near the middle of 
treatment.   
 
Figure 11 plots the average uncertainty of the predictions for all the lesions versus the day the 
prediction was made for.  The graph starts at day 18, since day 17 was the last day the model was 
allowed to have data from.  Since most tumors only grow a small amount from one day to the 
next, the model can correctly predict the change in volume for day 18, and the uncertainty is low.  
However, after only several days the uncertainty begins to increase.  The graph illustrates that 
the tumor response relationships themselves increase in complexity toward the middle of the 
treatment course, and the predictors are more varied, which increases the uncertainty.  
Respiration motion and contouring variations can result in fraction-to-fraction variations in the 
measured tumor volumes; these may not represent actual changes in volume.  It would be 
interesting to see how much the uncertainty during the middle of treatment could decrease with a 
larger database of lesions.   
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Figure 11  Average Uncertainty for all lesions versus Day of Prediction. 
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variable, and the additional patient data were included as observations, it was impossible to use 
local bandwidth optimization to dampen out unimportant information.  This result was 
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points were attempted, along with various scaling methods.  Perhaps the LWR technique had 
trouble handling these categorical variables.  This is an area warranting further investigation. 
 
The 95% confidence intervals were analytically calculated for each of the 40 lesions.  The 
confidence intervals are shown in Figures 10 as error bars on the predicted volumes.  The 
confidence intervals are also listed in Table A-II for the LWR predictions of the volume on the 
final day of treatment.  The final volumes with the 95% confidence interval were also predicted 
correctly in cases where the tumor volumes did not change much over the course of treatment 
(lesions 1 and 12).  However, these predictions have larger confidence intervals.  These inflated 
confidence intervals are expected because the training set had few other examples of this 
behavior, and calculations showed that the model was being extrapolated outside its training 
region, thereby increasing the uncertainty. 
 
The predictive performance of the model will increases with the amount of training data.  In this 
study, volume data from the remaining 39 lesions were used for predicting change in volume for 
each tumor.  Because LWR is nonparametric, the memory matrix can be appended with new 
data.  As more patient data is added and the memory matrix grows, the predictive accuracy of the 
model should improve.  The local nature of LWR is also well suited for patient modeling.  Since 
each patient is unique and not all patients will respond the same, global techniques are less 
appropriate.  With local models, only observations which are similar to the current query are 
used to make the prediction.  Since there is varied response amongst the patients, the ability to 
dampen out observations from patients which are not responding in a similar manner as to the 
current patient is desirable. 
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3.4 TUMOR RESPONSE MODELING CONCLUSIONS 
A novel technique has been developed for predicting lung tumor response during radiation 
therapy.  This study expanded upon the original by including data from an additional 20 lesions 
(thus, a total of 40 lesions were included in the memory matrix).  Because LWR is 
nonparametric, the memory matrix was easily appended with this new data without having to 
retrain the model.  The predicted volumes and masses at the end of treatment highly agreed with 
the true final volumes and masses, and the additional data did improve the model’s accuracy.  
However, inclusion of patient information (such as type of tumor and dose) did not improve the 
model performance as expected.  Overall, this study confirms that predictive modeling, 
specifically in the context of PART, has the potential to improve radiation therapy.  By knowing 
the expected volume change in a tumor as early as the third fraction of treatment, care can be 
taken to ensure that the tumor volume remains in the treatment field throughout the entire 
treatment course.  LWR predictions could also be used in the design of an intensity modulated 
integrated boost to the location of the residual tumor.   
 
Additional studies are needed to determine if there is a correlation between the predicted tumor 
response during treatment and clinical outcomes.  Future research hopes to add PET images 
acquired before, during, and after treatment into the model and to also correlate patient survival 
with model predictions.  It would also be interesting to extend PART beyond just lung tumors 
and investigate modeling different anatomical sites. 
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4. VERIFICATION OF HELICAL TOMOTHERAPY DELIVERY USING 
AUTO-ASSOCIATIVE KERNEL REGRESSION 
 
Beyond the clinical necessity of ensuring the patient's IMRT plan is correct, billing codes which 
must be submitted for reimbursement from Medicare and insurance companies also state that 
patient specific IMRT QA must be completed prior to the patient starting treatment.  This means 
that performing patient specific QA for all new IMRT patients is not just good clinical practice; 
it also is a regulatory requirement.  Unfortunately, performing patient specific QA can be fairly 
time consuming.  Even with the advances in portal dosimetry and other QA measurement tools, 
it still takes time and resources to deliver the plan and analyze and record the results. Having to 
re-QA the treatment plan each time it is modified is a major hurdle in implanting PART.  Most 
departments simply do not have the personnel to support constantly reshooting the QA.  With 
that in mind, methods for automating the QA process have been investigated.   
 
This chapter describes the development of a nonparametric modeling technique developed to 
monitor nuclear plant sensor data can also be applied to model tomotherapy data.   Researchers 
at the University of Tennessee developed auto-associative kernel regression and found that this 
modeling scheme had excellent performance on the nuclear plant data and could predict correct 
sensor values when supplied a group of corrupted or faulty sensor values.  Although the 
modeling scheme is young, the promising results from the nuclear plant data, made me wonder if 
it could also be applied to the field of radiation therapy.  After considering the possible 
applications, I then realized that the exit dosimetry data from the helical tomotherapy system 
does not differ much from data collected at nuclear plants.  Although exit dosimetry data have 
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considerably higher dimensionality, making the problem more complicated, I still believed the 
modeling technique could work.  The following sections will outline the process of developing 
the model with the tomotherapy sinogram data and communicate the AAKR results. 
 
4. 1  INTRODUCTION TO AAKR FOR ERROR DETECTION 
As previously mentioned, the clinical process for intensity modulated radiation therapy (IMRT) 
often requires quality assurance (QA) testing for individual patients to verify that the correct 
dose (and dose distribution) is delivered to the correct target site in the body [Molineu et al 
2005].  This IMRT QA process requires lengthy measurements before each patient’s first 
treatment, and again after any changes (such as re-plans, boosts, and adaptations).  When PART 
becomes available, the IMRT treatment delivery sequence will be adjusted prior to each 
treatment session to compensate for changes in the position, size, and deformation of internal 
anatomy.  As such, it will be impossible to perform an IMRT QA analysis prior to treatment 
delivery without moving the patient.  
 
Schemes for verifying the delivery of the correct fluence or dose to the patient using electronic 
portal imaging devices (EPIDs) have become a subject of considerable interest.  Most studies 
have focused on the application of EPIDs designed for patient setup verification during radiation 
therapy.  The most commonly used systems are video-based EPIDs, scanning liquid-filled 
EPIDs, and amorphous silicon arrays, and each system has its own advantages and 
disadvantages.  Recently, Dempsey [2006] et al. developed a custom EPID that employs a fast 
scintillator and a high-speed camera to experimentally characterize static and dynamic IMRT 
delivery.  The vast majority of EPID studies have focused on IMRT verification with either no 
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material placed in the path of the beam, or with homogonous build-up material placed on the 
EPID [Louwe et al. 2006].  Few EPID studies have performed IMRT verification with an 
anthropomorphic phantom in the beam, and even fewer have performed verification for actual 
treatment deliveries in patients [Warkentin et al. 2003].  
 
In helical tomotherapy treatment delivery, exit dosimetry data are acquired for each patient by a 
CT detector array located opposite the linear accelerator on a rotating slip-ring gantry.  This data 
is stored in the tomotherapy record and verified automatically for each treatment fraction.  
Unfortunately, techniques developed for performing IMRT patient QA with EPID detectors 
cannot be applied to tomotherapy detector data.  This work aimed to develop a novel technique 
for automatically evaluating exit dosimetry on a helical tomotherapy system using auto-
associative nonparametric modeling that is robust and has the capability to learn complex 
detector data relationships, even with low temporal resolution of detector data and patient beam 
attenuation.   
 
4.2 METHODS AND MATERIALS 
As mentioned in Chapter 2, the tomotherapy detector array collects and stores exit dosimetry 
data during treatment delivery in the form of sinograms.  These sinograms contain a record of the 
radiation exiting the multi-leaf collimator and passing through the patient during the treatment 
(Figure 12).  In the figure, the left panel shows a macroscopic view of the detector data, and the 
right panel shows an enlarged view of 6 projections.  All MLC leafs are closed at the beginning 
and the end of each projection.  The intensity is modulated by adjusting the time that each MLC 
leaf is open for each projection.  The tomotherapy sinograms consist of the expected beam 
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intensity at the detector array for each gantry angle and couch position.  This intensity pattern is 
referred to as a “sinogram” because each point irradiated in the patient maps a sine wave pattern 
at the CT detector as the gantry revolves.  The horizontal axis in the sinogram represents the X-
ray fluence incident on the detector array, while the vertical direction is a function of projection 
angle.   
 
Figure 12  Raw detector sinogram data for helical tomotherapy treatment delivery. 
 
A projection is the planned fluence at a particular gantry angle.  The intensity of the sinogram is 
low for regions of low radiation fluence (i.e., under a closed MLC leaf), while the high intensity 
values represent regions where radiation is exiting the MLC.  This sinogram data can be accessed 
in uncompressed format (300 frames per second) immediately after treatment delivery from the 
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tomotherapy data acquisition system (DAS), which is an on-board computer process system 
located in the gantry.  The treatment delivery sinograms are stored in the tomotherapy relational 
database.  The detector data for clinical patients are compressed per projection.  There are 51 
projections per rotation, and the gantry rotational period ranges from 10–60 seconds.  The stored 
detector data is the cumulative signal acquired during each projection, which ranges from 0.3–
1.2 seconds.  This detector data is referred to as “compressed” data. 
 
The compressed sinogram exit detector data contains valuable information regarding the 
integrity of the treatment.  Thus, the analysis of compressed sinogram detector data could 
become a critical component of IGRT quality assurance (QA).  Unfortunately, this analysis is not 
as straightforward as it may seem.  Even with accurate setup, a patient’s breathing and 
anatomical shifts will cause the beam’s attenuation to slightly vary at each treatment.  This 
change in attenuation is reflected in the compressed sinogram detector data.  Because of the 
difference in attenuation, direct comparison between treatment sinograms using simple 
sinogram-sinogram subtraction is not always able to discern small errors (such as the incorrect 
opening of a single MLC leaf).  Although sinogram-sinogram subtraction is able to detect gross 
errors, since the nature of MLC leaf errors in actual treatment delivery is unknown, another 
method is needed to distinguish positional errors of individual MLC leaves.  When analyzing the 
uncompressed data, geometric shape detection can be used.  Chen et al. [2012] describe how a 
Richardson-Lucy deconvolution can be used to help remove some of the scattering and 
penumbra that “pollute” the uncompressed sinogram data to make the geometric detection more 
meaningful. 
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Unfortunately, even the Chen et al. [2012] study admits that the majority of uncompressed raw 
data poses a workflow issue, as it takes several minutes to transfer after each delivery and a new 
patient cannot be pulled up during the transfer.  The large file size also renders the analysis 
extremely time consuming and nearly impossible to conduct for every treatment delivered.  
Thus, it would be ideal to analyze the compressed data.  However, because of the compression, 
the compressed detector data do not match the instantaneous MLC shapes but their average over 
a projection.  In order to analyze this compressed data, a new technique had to be developed.  
This technique uses an auto-associative kernel regression (AAKR) model.  This technique uses 
the exit detector data from several historical treatment sinograms to develop the model.  A new 
sinogram detector dataset is then applied to the model and the “true” or “error-free” value for 
each projection in this set is predicted.  These predictions are compared to the values of the 
actual projections to determine if errors are present.  Although the sinogram detector datasets 
have different attenuations, the model is capable of learning the relationships and accounting for 
these differences.  Thus, when comparing the predicted and actual values, the only errors to 
appear result from errors in the delivery, such as errors in the MLC leaves or machine output.  
 
4.2.1 AUTO-ASSOCIATIVE KERNEL REGRESSION (AAKR) THEORY 
AAKR modeling is a novel nonparametric modeling technique developed by researchers at the 
University of Tennessee [Hines and Garvey 2006].  To understand auto-associative kernel 
regression, the basic principles of kernel regression must be understood.  As discussed in the 
previous chapters, kernel regression (KR) is the process of estimating a parameter’s value by 
calculating a weighted average of historical, exemplar observations.  It is a well-known 
technique in statistics and empirical modeling.  Generally, KR may be most compactly 
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represented by the so-called Nadaraya-Watson estimator.  For a simple single-input, single-
output (SISO) regression model, where the input x is used to estimate the output y, the Nadaraya-
Watson estimator is as follows: 
n
i
i
n
i
ii
xXK
YxXK
xy
1
1
 
ˆ , (4-1)     
where: n is the number of exemplar observations in the KR model 
 Xi and Yi are the input and output for the i
th
 exemplar observation  
 x is a query input 
 xXK i  is a weighting or kernel function, which generates a weight (similarity) for a 
given difference of a query from an exemplar vector 
 xyˆ  is an estimate of y, given x. 
To fully explain KR, Equation 4-1 must be dissected.  Overall, the equation performs 3 steps to 
arrive at its final prediction.  For a query observation of the inputs, the KR estimation process 
first calculates the distance of the query from each of the input exemplars.  An input exemplar is 
simply a historical observation of the variable being predicted.  Thus, in this study, an exemplar 
is a fluence measurement found in the exit detector data used to construct a model.  A query is 
then a fluence measurement from the exit detector data that is tested, or whose values are 
predicted by the model.  The distance is simply a mathematical measurement of how far the 
query or the predicted fluence value is from the exemplar (the fluence values stored in memory).  
Next, the distances are supplied as inputs to a kernel function, which converts the distances to 
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weights (similarities).  Finally, the weights are used to estimate the output by calculating a 
weighted average of the output exemplars.  These steps are depicted in Figure 13. 
 
Figure 13  Diagram depicting the kernel regression process.   
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To understand the process shown in Figure 13, first consider the exemplar inputs X and outputs 
Y.  These observations represent the “memory” of the KR model and are therefore often referred 
to as memory observations or memory vectors.  In terms of the sinogram detector data, the 
memory vectors are the historical detector datasets used to develop the model.  The input 
exemplars contain the sinogram detector data from past treatments.  The columns in the input 
matrices represent projections in the historical detector data, while the rows represent each 
individual detector.  Each observation or exemplar in X is then a fluence measurement (or 
detector count) from the particular detector for the given projection.  In other words, each 
projection in the historical measured sinogram detector data is considered a variable, while 
fluence measurement in that projection is an observation. 
 
Next, consider the query input xq.  This query input xq is a vector or matrix of the data being 
applied to the model.  For this study, xq contains the detector measurements for a given 
projection from the current treatment being analyzed.  The observations in xq are the KR model 
inputs and will be used to predict the output.  To predict the output, it must first be determined 
how far the query is from the exemplar inputs.  This is accomplished by evaluating a distance 
measure with each exemplar input and the query input as arguments.  The distance calculation 
for the i
th
 exemplar observation is represented by 
qid xX , .  Notice that this calculation is 
repeated for each exemplar input, suggesting that the result of this entire operation is a vector of 
n distances d, which contains the distance of the query to all of the input exemplars.   
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At this point, the distances of the query to each of the input exemplars have been obtained and 
must be converted to weights or similarities.  This is accomplished by evaluating a similarity or 
kernel function for each of the distances.  For the vector of n distances d, the kernel function 
results in a vector of n weights w, which represent the similarity of the query to each of the input 
exemplars. 
 
In the final step of the prediction process, the similarities of the query to each of the input 
exemplars are combined with the output exemplars to obtain estimates of the output.  For KR, 
this is accomplished by calculating a weighted average of the output exemplars using the 
similarities of the query to the input exemplars as weighting parameters.   
 
The KR prediction process can also be thought of as answering the following question: “Based 
on observed inputs X and outputs Y, what will be the system output for a new query input xq?”  
To answer this question, the following 2 questions must be answered first: 
 
1) How similar is the query to the known inputs X?  
2) The similarities of the query to the known inputs X can be used to measure which model 
outputs are most likely to occur.  How do we aggregate these similarities to estimate the 
model output?  
 
Now that the general process used in KR has been presented, Equation 4-1 can be revisited to see 
how each step is carried out, beginning with the distance calculation.  The distance measurement 
used in Equation 4-2 can be seen as simply the difference of the input exemplar and the query: 
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  (4-2) 
 
The specific distance function used in this research is the Euclidean distanceError! Reference 
ource not found., which is also known as the L
2
-norm.  For a single input, the Euclidean 
distance for the i
th
 input exemplar and a query is given by the equation: 
 
2 
 qiqi xXx,Xd .  (4-3) 
 
For p inputs, the Euclidean distance becomes: 
 
2 
,,
2 
2,2,
2 
1,1,, pqpiqiqiqi xXxXxXd xX  (4-4) 
 
where: Xi is the i
th
 exemplar observation of the p inputs, and 
xq is the query observation of the p input variables, and xqj is the query observation of the 
i
th
 input variable. 
 
The distances calculated in Equation 4-4 are used to estimate the similarities via the kernel 
function K.  These similarities can be interpreted as being weights and using the notation w to 
represent a vector of n weights as described above, the equation for the i
th
 weight (similarity) can 
be written as follows: 
 
., qiqi xXxXd
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qii xXdKw , . 
(4-5) 
There are many kernel functions that are used to transform distances into similarities.  Figure 12 
depicts many of these functions.  In general, a kernel function should have large values for small 
distances and small values for large distances.  In other words, when a query point is nearly 
identical to a reference point, its distance should be small and, therefore, that particular reference 
point should receive a large weight and vice versa.  Although each function shown in Figure 14 
may have advantages or disadvantages in certain situations, Scott [1992] and Cleveland and 
Loader [1994] demonstrated in their studies that kernel function selection plays a non-critical 
role in the performance of locally weighted models.   
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Figure 14  Examples of some common kernel functions. 
 
The Gaussian kernel function (Figure 15) is an adequate selection, and was selected as the 
function for this research.   
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Figure 15  Example of the Gaussian kernel. 
 
The Gaussian kernel is shown in the following equation: 
2
2
2
2 2
1
h
d
h e
h
dK . (4-6) 
Here, h is commonly referred to as the kernel’s bandwidth and used to control what effective 
distances are deemed similar.  For mean-centered, unit-variance scaled data, the bandwidth 
generally has values on 10 h .  Figure 15 illustrates that the Gaussian kernel with the smaller 
bandwidth (h = 0.1) will only generate large weights when the distance is very close to 0, while 
the kernel with the larger bandwidth is less specific and will assign greater weights for a larger 
range of distances.  For this application, a very small bandwidth is used, only a relatively small 
number of memory vectors (or fluence measurements from previous treatments stored in 
memory) will influence the estimated value of the fluence measurement from the treatment being 
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tested.  However, if a very large bandwidth is used, there will be more significant weights, and a 
relatively large number of memory vectors will influence the estimated fluence value.  Such a 
kernel function would then smoothen the AAKR’s input-output relationship.  Small bandwidths 
generally produce rough or non-smooth input-output relationships, while large bandwidths 
generally produce smooth input-output relationships.  If the bandwidth is very small, there is a 
risk that noise in the data will be modeled.  Conversely, a very large bandwidth will result in, 
overly smooth predictions, which renders detecting small errors in the measured detector data 
impossible.  Therefore, the kernel must be optimized to identify the ideal bandwidth value. 
 
After the Gaussian kernel converts the distances to similarities, the estimated similarities are to 
perform a weighted average of the output exemplars.  Notice that in Equation 4-1, the sum of the 
weighted output exemplars is divided by the sum of the weights.  This operation is simply a 
normalization that allows for the prediction to be represented as a “mix” of the output exemplars 
where each exemplar can have an influence of 0–1 (0–100%). 
 
The methods for mapping an input query to similarities have already been discussed, and the 
different model architectures can now be examined in greater detail.  There are 3 different KR 
architectures—inferential, heteroassociative, and auto-associative—that characterize the number 
and type of inputs and outputs. 
61 
 
 
Figure 16  Illustration of (a) inferential, (b) heteroassociative, and (c) auto-associative model architectures. 
 
As seen in Figure 16, an inferential model uses multiple inputs to infer an output, a 
heteroassociative model uses multiple inputs to predict multiple outputs, and an auto-associative 
model uses inputs to predict the “correct” values for the inputs, where “correct” refers to the 
relationships and behaviors contained in the exemplar observations.  Thus, the auto-associative 
architecture is most suited for this application.  For auto-associative kernel regression (AAKR), 
the inputs are “corrected” by performing a weighted average of the input exemplars:   
 
(a) 
 
 
(b) 
 
 
(c) 
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where:  the scalar a is defined as the sum of the weights, i.e., 
mn
i
iwa
1
.   
As shown in Equation 4-7, with an auto-associative architecture, a model’s inputs and outputs 
are the same variables.  These models have outputs trained to emulate the inputs over an 
appropriate dynamic range.  Since data is often corrupted by noise, faults, and/or biases, an auto-
associative model may be used to estimate the input’s “correct” value.  Here, “correct” refers to 
the values used to train the model.  In other words, an auto-associative model will act to correct 
its input to those values that are in agreement with the correlations (relationships) embedded in 
the model during its training.  A model’s output will be a corrected version of the model input.  
If the inputs are faulty, this model should predict the un-faulted values under normal operating 
conditions.  An AAKR model should be able to learn the relationships present between detector 
data from different treatments.  Thus, when a model is developed with detector data from several 
treatments and tested with the current treatment, the correlations between the data should be 
normal unless there is some type of fault, such as an MLC error.   
 
Auto-associative modeling is a new and innovative technique with wide application in the field 
of sensor fault detection.  The AAKR model used in this research was developed and tested 
using code written in MATLAB version R2006b.  
 
The memory matrix (X) and the kernel bandwidth (h) need to be optimized in an AAKR model.  
The developer must decide how many vectors to include in the memory matrix and how large to 
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make the bandwidth, which indirectly controls how many memory vectors are weighted heavily 
during prediction.  Since the model's objective is to detect and quantify errors in the measured 
sinogram detector data, the model should be made as immune as possible to faulted data, which 
can be accomplished through optimization.  Previous studies have investigated and reported 
optimization techniques [Hines and Usynin 2005; Wegerich 2002].  
 
In this study, the AAKR model was optimized by performing a combinatorial grid search of the 
input parameter values.  To begin the grid search, the user first defines the acceptable values for 
one or more of the model’s initialization settings.  Next, each combination of the initialization 
settings is used to construct a prototype model that is tested and scored.  For this study, 
acceptable values for the kernel bandwidth were defined as 0.1–3 in increments of 0.1.  This 
range is representative of typical kernel bandwidths; further, a bandwidth of 0.1 appeared to 
overfit the solution while a bandwidth of 3 over-smoothed it.  Acceptable values for the number 
of memory vectors were defined as ranging from 1–543 in increments of 1, as there are a total of 
543 fluence measurements in each projection.  The grid search returned the model with the 
parameter combination that minimized the mean sum of the squared error (SSE) between the 
model predictions and the test data.  These parameters were used in all future models.  For this 
study, all of the vectors were included in the memory matrix and a bandwidth of 0.41 was used. 
 
4.2.2 AAKR UNCERTAINTY 
Since this technique could eventually be used to find errors in actual patient treatment, each 
model prediction must be accompanied by an estimate of its uncertainty.  The inaccuracies in the 
training data and inherent limitations of the model contribute to the total uncertainty of these 
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techniques.  More specifically, the selected predictor variables, the amount and selection of data 
used to develop the model, the model structure including its complexity, and the noise in the 
predictors and response (such as electrical contamination of the signal and board-induced, EMI 
(electromagnetic interference)- and RFI (radio frequency interference)-induced noise associated 
with the data acquisition) all influence the uncertainty.  The uncertainty estimate reveals how 
accurate the model is and can also play a role in determining the threshold for error detection.  
The uncertainty of each AAKR prediction can be computed by using Monte Carlo methods 
[Efron 1993]0 or analytically determined [Gribok 2004].  For an approximate 95% confidence 
level, the analytical uncertainty for an AAKR prediction is computed with the following 
equation: 
 
2222ˆ Biashhx Tq   (4-8) 
where: 2 is the variance of the error or noise in the measured sinogram detector data 
h is the hat matrix of the weights given  by 
a
w
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w
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and the bias is defined as the model’s systematic error and estimated by calculating the 
difference between the model’s expected prediction, )ˆ( qxE , and an estimate of its “true” 
value xq. 
 
Equation 4-8 gives the 95% prediction interval for an AAKR estimate.  This prediction interval 
gives the upper and lower bounds between which there is a (100 – ) × 100% probability that the 
true output of the model prediction (at input xq) lies.  Unlike the commonly used confidence 
interval, the prediction interval is concerned with the confidence in the prediction of the targets.  
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The confidence interval only accounts for the variance component of the uncertainty and 
neglects the noise portion.  Thus, the prediction interval is a much more practical parameter than 
the confidence interval because it provides the accuracy with which the desired response can be 
predicted, and not just the accuracy of the model itself.  
 
4.2.3 SINOGRAM TESTING 
When applying this AAKR model to the measured sinogram detector dataset, each of the 
predicted output vectors will be an error-corrected version of the input vectors.  A properly 
developed model will produce predictions that show virtually no change when the corresponding 
input has been distorted by noise, faulty data, or missing data.  This characteristic allows the 
auto-associative model to detect MLC errors or machine output errors by comparing each model 
input projection to the corresponding model estimates of the projections.  If a projection that is 
entered into the auto-associative model is faulty due to an MLC positional error or machine 
failure, the model still produces a reasonably valid estimate of the correct projection as it obtains 
information from other correlated projections. 
 
To test the ability of AAKR to detect errors in the measured sinogram detector data, the helical 
tomotherapy MLC controller files were extracted for 3 patients with tumors at different locations 
(1 head and neck, 1 prostate, and 1 lung) who had completed radiation treatment.  The MLC 
controller files were modified by reducing the opening time of individual MLC leaves in specific 
projections by known amounts.  Table 2 lists the inserted errors and their location in the delivery 
sequence for each case.  The resulting error did not only depend on the percent reduction in the 
closing time of individual MLC leaves but also on how long the leaf was originally open in the 
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projection and its position in the given projection.  The modified treatments are referred to as the 
“treatments with errors,” and the unmodified treatments are referred to as “error-free.” Treatment 
procedures with and without the known errors were manually created and delivered using the 
tomotherapy Calibration Data Interface.  These treatments were delivered multiple times with 
different objects in the path of the beam in order to test the AAKR model’s error detection 
capabilities in the presence of attenuation. 
 
Table 2 Key for the errors that were intentionally inserted into the delivery sequence from actual patient treatment 
plans 
% 
Error MLC Projection
Error 
(msec) MLC Projection
Error 
(msec) MLC Projection
Error 
(msec)
30 30 120 48.0 24 140 41.0 30 120 82.0
28 31 140 50.4 25 180 39.2 25 140 31.7
26 32 160 44.2 26 220 54.6 45 160 29.5
24 33 180 38.4 36 260 11.2 20 180 36.8
22 34 200 29.3 30 300 40.3 40 200 33.7
20 30 220 29.3 24 340 20.7 30 220 58.0
18 31 240 25.2 40 380 18.6 20 240 27.0
16 32 260 22.4 26 420 18.7 45 260 27.2
14 33 280 18.2 36 460 10.7 20 280 22.9
12 34 300 14.0 37 500 12.8 35 300 20.8
10 30 320 13.3 24 540 9.7 40 320 7.3
8 31 340 11.5 25 580 4.0 20 340 11.5
6 32 360 9.2 26 620 6.2 45 360 7.8
Head and Neck Prostate Lung
 
For both the prostate and head and neck treatments, a total of 6 delivery sequences were 
delivered. (1) No error with only the couch in the path of the beam, (2) error with only the couch 
in the path of the beam, (3) no error with a cylindrical phantom in the path of the beam, (4) Error 
with a cylindrical phantom in the path of the beam, (5) no error with an anthropomorphic 
phantom in the path of the beam, and (6) Error with an anthropomorphic phantom in the path of 
the beam.  For the lung treatment, the same 6 delivery sequences were delivered, and additional 
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error and error-free treatments were delivered with a standard imaging (Middleton, WI) 
respiratory gating phantom in the path of the beam.  The error and error-free lung plans were 
delivered with the phantom’s longitudinal motion set to 5, 20, and 40 mm, with cycles ranging 
from 2–6 seconds.  These combinations of amplitudes and phases were designed to replicate a 
wide range of different breathing patterns. 
 
4.2.4 DOSIMETRIC IMPACT  
The dosimetric impact of the MLC errors listed in Table 2 was evaluated for each of the test 
cases used in this study.  The original unmodified dose distributions for each of the 3 test cases 
were extracted from an archived copy of the patients’ plan.  In addition, the files that define the 
MLC positions for dose calculation were also extracted.  These files were then modified by 
inserting the known MLC errors for each test case.  The doses were then recalculated with the 
modified MLC files using the tomotherapy planned adaptive dose reconstruction tool.  
Megavoltage CT (MVCT) images were not used during the dose reconstruction.  The dose 
recalculation was performed using the same treatment planning CT dataset and contours as the 
original treatment plan.  The only difference between the original treatment plan and the 
recalculated doses was the change in the MLC positions.  Once the doses were recalculated, dose 
volume histograms (DVHs), isodose distributions, and dose difference maps were created using 
the planned adaptive tools. 
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4.3 RESULTS AND DISCUSSION 
The auto-associative kernel regression (AAKR) modeling process described above is a new and 
“cutting edge” technology that has only recently been applied in industry.  To date, AAKR or 
any similar modeling paradigm have never been used in the field of radiation therapy.  Since 
AAKR is novel to radiation therapy, a straightforward study was conducted to test if it was a 
feasible technique that could help improve quality assurance.  Multiple AAKR models were 
developed and tested by the investigators by using combinations of the measured detector data 
sets.  This step is analogous to measuring a fluence intensity map during IMRT patient QA.  The 
model was then optimized using the combination grid search method described above.  The 
optimization process took nearly 3 minutes.  However, optimization only had to be done once.  
All future models (using the selected optimal bandwidth and number of memory vectors) took 
less than a minute to develop.  Models were developed using the error-free or unmodified 
sinogram detector data from the delivered treatments, and then tested using the detector data that 
had been modified to contain the known errors.  However, models were never developed with 
data which had the same attenuation (or the same object in the path of the beam) as the dataset it 
was testing.  This restriction verified that the model was robust to changes in attenuation, and 
could identify MLC and output errors even when the plan was delivered with different objects in 
the path of the beam.  Figures 17, 18, and 19 present typical results for the AAKR models.   
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Figure 17 MLC positional error for the prostate test case (A) with and (B) without known errors. 
 
As shown in Figure 17, the AAKR model correctly identified an error in the opening and closing 
of a leaf in projection number 260 for the prostate test case.  In this example, the prostate 
treatment delivered with known errors had a single MLC leaf with an intentional decrease of 11 
msec in the leaf opening time due to attenuation by an anthropomorphic phantom.  This result 
proved that the AAKR technique correctly identified that a MLC leaf opened with a delay of 5.5 
msec and closed 5.5 msec early from compressed exit detector data. 
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Figure 18 MLC positional error for the H&N test case (A) with and (B) without known errors. 
 
Figure 18 shows similar results for the patient with the head and neck tumor.  The model results 
shown in Figure 18 came from an AAKR model developed with sinogram detector data from the 
no error with only the couch in the path of the beam and no error with cylindrical phantom in the 
path of the beam deliveries.  The results were then tested with the measured sinogram detector 
data from the error with an anthropomorphic phantom in the path of the beam delivery.  In this 
example, the AAKR technique correctly identified MLC timing errors of 10 msec.   
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Figure 19 MLC positional error for the lung test case (A) with and (B) without known errors. 
 
Figure 19 shows the result from a single projection of the error and error-free delivery to the 
lung.  The model was developed with sinogram detector data from the no error with only the 
couch in the path of the beam and no error with a cylindrical phantom in the path of the beam 
deliveries.  The model was then tested with detector data from the error and error-free deliveries 
with the motion phantom in the path of the beam.  In this example, the motion phantom had its 
longitudinal motion set to 40 mm and the cycle set at 2 seconds.  Using measured detector data 
from deliveries with stationary objects in the path of the beam to develop the model, and testing 
it with data from deliveries with motion illustrated that the model is not degraded by changes in 
the breathing pattern or patient motion that occurred during the treatment.  The AAKR algorithm 
was still able to detect the MLC errors in the presence of simulated respiration.  These figures are 
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only select highlights from the many models that were developed and tested in this study.  The 
results presented are characteristic for all the cases tested. 
 
The results shown in figures 17, 18, and 19 illustrate that the model correctly distinguished the 
MLC positional error from changes in attenuation caused by the phantoms.  Furthermore, the 
model was capable of identifying errors in compressed detector data that had been summed over 
70–100 frames.  In general, errors greater than 7 ms were visually discernible by examining the 
model’s prediction of the fluence values in comparison to the actual measured fluence values.  
Smaller errors could be detected, but the errors that were detected generally depended on the 
position of the erroneous leaf in the projection and the actual shape of the projection.  In this 
study, only visual inspection of the predictions was used to identify errors.  It is possible that 
more sophisticated statistical logic tests could be able to detect smaller errors in the prediction 
and also enable complete automation of this method.
 
 Determining the true threshold of error 
detection and applying statistical logic testing are potential areas for future research. 
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Figure 20 AAKR Model Predictions for Projection 212 of the prostate (a) Error with a cylindrical phantom in the 
path of the beam sinogram detector data and (b) No error with a cylindrical phantom in the path of the beam 
sinogram detector data illustrating how the  model can detect machine output errors. 
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Figure 20 shows a different projection of a model testing detector data from the prostate “error 
with a cylindrical phantom in the path of the beam” delivery.  In this figure, an output error 
occurred while the “no error with a cylindrical phantom in the path of the beam” treatment 
sequence was being delivered.  This error was not intentionally inserted into the delivery 
sequence, and represents a real error that was detected by the model.  The measured fluence was 
13% lower than expected for all the MLC leaves in the high fluence region.  The output of the 
system is measured and recorded using the ionization chambers located in the head of the 
accelerator.  This data is stored in the detector data and was used to verify that there was a 
temporary decrease in machine output.  The tomotherapy system will be interrupted if the output 
is 50% lower than the intended value for a duration of 1 second, or 5% lower than the intended 
value for 10 seconds.  In this case, the output dropped by 13% for one projection (0.3 seconds), 
which would not trigger an interruption in the system.  This type of error can be easily 
distinguished from an MLC error.  In an individual MLC leaf error, only a few of the detectors 
(corresponding to the presence of the actual MLC leaf) would show mismatched values.  In 
contrast, in the case of an output error, all the detectors in that projection deviate from their 
predicted values.  The detection of this drop in output demonstrates that the AAKR model can 
detect real delivery errors.  
 
The results shown in figures 17, 18, 19, and 20 confirm that when a projection input into the 
auto-associative model is faulty due to an MLC positional error or machine failure, the model 
still gives a reasonably valid estimate of the correct projection due to its use of information from 
other correlated projections.  The results indicate that the AAKR model can learn complex 
detector data relationships, even with detector data with a low temporal resolution and beam 
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attenuation from the patient.  However, in these figures, the model uncertainty is not shown.  If 
the model uncertainty is large, there can be no confidence that the results seen in the figures are 
reflective of actual errors during the delivery.  Rather, with large uncertainties, it becomes 
difficult to prove that a disagreement between a predicted value and the actual value is 
statistically significant. 
 
To determine model uncertainty, the model must be tested using un-faulted data.  Faulted data 
will inflate the uncertainty of an auto-associative model since the faulted test data is no longer 
representative of the training data.  In fact, atypically large uncertainty values are indicative of 
errors and can be used to check for faults.  In most auto-associative modeling schemes, an 
average uncertainty is calculated using data that is known to be good.  This average uncertainty 
is then used as a baseline for comparison and to determine detectability.   
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Figure 21 AAKR model predictions with their 95% prediction intervals for projection 310 of the prostate “Error 
with a cylindrical phantom in the path of the beam” sinogram. 
 
Figure 21 shows the predicted fluence values for projection 310 of the prostate “error with a 
cylindrical phantom in the path of the beam” sinogram detector data accompanied by their 95% 
prediction interval.  In this projection, no known error had been inserted into the delivery.  
Accordingly, no distinguishable errors were present in this sinogram, which is also reflected by 
the low uncertainty values.  This low uncertainty is evidence of the model’s accuracy.  In the 
high fluence area (i.e., the area where the MLC leaves were open), the average uncertainty was 
1.5% of the fluence value.  This uncertainty value was found to be typical for the un-faulted 
projections, with the average uncertainty ranging from approximately 0.4–1.8%.  The uncertainty 
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coverage for projection 310 was also calculated as 97.2%.  Coverage refers to the percentage of 
the test data which fall within or are “covered” by the prediction interval (prediction ± 
uncertainty).  For an accurate model testing un-faulted data, coverage is expected to be at least 
95% to correspond to the 95% confidence level used in calculating the prediction interval.  
Coverage values exceeding 95% are evidence that the AAKR model is well-specified.   
 
The low uncertainty values and good coverage values indicate that the AAKR model is 
extremely accurate in its predictions.  They also suggest that this AAKR modeling scheme may 
be able to reveal delivery errors that cause the fluence to change by less than 2%.  However, the 
model will only be able to detect delivery errors that are unique to the delivery being tested.  Any 
errors that occur in a systematic manner at every treatment will be considered as normal 
operating conditions, and the system will therefore not be able to detect them. 
 
The clinical impacts of the MLC errors measured in this study were tested using a dose re-
calculation technique developed by the investigators.  The original MLC sequence in the 
treatment planning system was modified to reflect the MLC errors.  The dose was then 
recalculated for each case and compared against the error-free doses.  In all 3 test cases, the re-
calculated doses with the known MLC errors was considerably less than 1% (Figure 22).  
Therefore, it is possible for the AAKR technique to detect MLC errors before they reach clinical 
significance.  One of the advantages of this technique is that it is independent of the tomotherapy 
MLC control system, which uses infrared tracking of the MLCs.  This technique can be used to 
verify that the tomotherapy MLC interlock system is functioning correctly.   
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Figure 22  The 0.1% dose difference isodose lines and the DVH values for the lung case with errors versus the lung 
case without errors.   
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Overall, the results of this study suggest that AAKR modeling could be used to monitor and 
eventually improve the reliability of radiation delivery.  In addition to analyzing sinogram 
detector data, the AAKR model could also be applied to EPID images acquired on other linear 
accelerator systems.  For this application, the x and y pixels in the EPID images would be 
considered variables, while the actual detector counts would be considered observations.  Using 
the same derivation, the model may be able to predict the “true” or “error-free” fluence values 
for each pixel. 
 
However, it is important to reiterate that this AAKR modeling technique is only capable of 
detecting random errors.  Any systematic errors will be masked and assumed to be the normal 
operating condition.  Also, the technique cannot be applied until several fractions have been 
delivered.  Thus, this technique cannot take the place of the standard IMRT patient specific QA.  
However, it is a valuable technique that provides valuable information about the integrity of the 
treatment.  It still has the potential help the implementation of PART.  It is possible a comparison 
between the planned vs. delivered sinogram could be conducted for the adapted plan in real time.  
Although this comparison will show some difference because of the variations in attenuation for 
the delivery, if the agreement was within 7% it could be safe to assume the adapted plan was 
valid.  The AAKR technique could then later be used to detect finer errors in the adapted 
delivery. 
 
4.4 SINOGRAM ERROR DETECTION CONCLUSIONS 
A novel technique was developed for automatically evaluating exit dosimetry on a helical 
tomotherapy system using auto-associative nonparametric modeling.  This technique was 
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capable of learning the complex detector data relationships, even in cases of detector data with 
low temporal resolution and beam attenuation from an anthropomorphic phantom.  In the initial 
development of AAKR, the algorithm was successfully able to process highly compressed 
detector data and identify minute errors of single MLC leaves.  Although the MLC errors that 
were intentionally introduced in this study have no dosimetric impact, being able to detect them 
illustrates that this method could provide early warnings for MLC leaf failures.  AAKR was able 
to predict the correct or “error-free” values for a projection where a single MLC leaf decreased 
its opening time by 8 milliseconds.  Moreover, the model also was able to determine machine 
output errors.  The average uncertainty value for the un-faulted projections ranged from 0.4–
1.8% of the detector signal.  The low model uncertainty indicates that the AAKR model is 
extremely accurate in its predictions and also suggests that the model may be able to detect errors 
that cause the very slight changes in fluence.  However, additional evaluation of AAKR is 
required to determine the minimum detectable error threshold from the compressed detector data.  
It is hoped that this technique will aid the implementation of PART. 
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5. CONCLUSIONS 
Over the past decade, nonparametric empirical modeling techniques have gained popularity in 
numerous engineering-driven fields as viable prediction, smoothing, and state estimation tools.  
In general, the medical community, particularly the subsection involved in radiation therapy, has 
been slow to adopt these new techniques. However, these techniques are especially suited to this 
field, as their local characteristics are ideal for modeling patient data.  This work has proven 
nonparametric modeling’s usefulness in radiation therapy, as it relates to the development and 
implementation of Predictive Adaptive Radiation Therapy (PART).   
 
The focus of this dissertation has been on introducing the concept of PART for lung tumors.  To 
demonstrate PART, a nonparametric model was developed and tested on its ability to predict 
lung tumor response during image-guided radiation therapy treatment (IGRT). Volumetric 
computed tomographic (CT) images acquired by IGRT systems were used to measure tumor 
response over the treatment course.  In this study, a patient database containing IGRT image data 
for 40 lesions obtained from patients who were imaged and treated with helical tomotherapy with 
doses ranging from 2.0–2.5 Gy per fraction was constructed.  The changes in volume and mass 
over elapsed days were modeled using a LWR model. The LWR was able to predict future tumor 
volumes and masses as well as the associated confidence intervals based on observations from 
only the first two weeks of treatment. To test the predictive accuracy of the model, a leave-one-
out cross-validation technique with the measured tumor responses was used. The findings 
showed that the absolute mean error for prediction of the mass and the final volume were 10.2% 
and 8.4% respectively. An addition of the patient data led to decrease in the absolute mean error. 
The greatest model uncertainty was recorded near the middle of the treatment, where the 
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predictors were varied and complex tumor response relationships. It can be concluded that since 
the predictions were accurate based on the quantified uncertainty, they can be used to adapt a 
patient’s treatment and help decide if an intensity modulated integrated boost to the location of 
the residual tumor would be beneficial.  Thus, PART is a feasible technique for lung 
radiotherapy. 
 
However, adaptation of a treatment plan will require more patient specific QA, which could be a 
large drain on department resources.  With that in mind, an auto-associative kernel regression 
(AAKR) model was applied to tomotherapy delivery sinograms with the goal of detecting errors 
during tomotherapy delivery. This particular modeling scheme is especially suited for monitoring 
the exit detector data. This model is capable of learning the relationships in the detector data, 
even when different degrees of beam attenuations and low temporal resolution as a result of 
patient’s movement are recorded. Thus, the model should be able to distinguish random errors in 
the delivery (such as dropped pulses, or a misfiring MLC leaf) from the normal relationships 
caused by beam passing through the patient as he breathes.  To determine the model’s 
performance, multiple AAKR models were developed and tested using combinations of the 
measured detector data sets.  However, models were never developed with data which had the 
same attenuation (or the same object in the path of the beam) as the dataset it was testing.  This 
restriction verified that the model was robust to changes in attenuation.  The developed models 
proved to be reliable, as they could predict the correct error free values especially for an auto-
associative kernel regression (AAKR) model.  Models of a projection that had “no known error” 
inserted into delivery, showed no distinguishable errors in the sonograms, which is evidence of 
the model’s accuracy. On the other hand, comparison of the model predictions and measured 
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detector data for the modified projections (which was a projection where an MLC error had 
purposefully been inserted) made it clear that the model was correctly predicting the unfaulted 
fluence values.  The low uncertainty values were further indicators of the model’s accuracy.  
Thus, the AAKR model could serve as a prognositic tool for the tomotherapy system and provide 
warning of machine faults.  However, it must be reiterated that this AAKR technique can never 
be the only form of machine QA because it will always consider errors that are occurring in a 
systematic manner as normal operating conditions and allow them to go undetected. But the 
technique shows promise as a prognostic tool.  And it is hoped that when coupled with an on-line 
sinogram comparison method, it could still be used to ease the implementation of PART. 
 
5.1 RECOMMENDATIONS FOR FUTURE WORK 
There are several future directions for related work.  In the lung response study, a promising area 
for further research is trying to correlate the predicted tumor response during treatment to clinical 
outcomes. However, for the correlation to be significant, a much larger database of patients is 
required, as well as many years of follow up data.  It would also be interesting to add PET 
images acquired before, during, and after treatment into the model and see if this functional 
information will improve the model performance.  Another area of future work is to extend 
PART beyond just lung tumors and investigate modeling different anatomical sites.  However, 
only sites which have tumors whose response is visible on the daily IGRT images can be 
considered. 
 
More research is also needed before the AAKR technique can be implemented clinically.  Full 
automation of the technique is still an area warranting further research.  It may even be possible 
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to employ the method in an on-board treatment computer.  Once implemented, deciding how 
much of a reduction in traditional IMRT QA is appropriate and will not affect patient safety is 
another task that needs to be performed. 
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APPENDIX A.  PATIENT TABLES 
 
Table A-I.  Patient Information  
Lesion 
#: 
 
Age: Dose: Stage: TNM: Pathology: Chemotherapy: 
Current 
Survival 
Survival 
at Time 
of Death 
1 
 
73 60 II  T1N0M0 Adeno No 20 -- 
2 
 
56 62 I T1N0M0 Adeno Concurrent 31 -- 
3 
 
81 64 I T1N0M0 Adeno No 14 -- 
4 
 
65 70 I T1N0M0 Adeno Concurrent -- -- 
5 
 
67 70 I T1N0M0 Squam No -- -- 
6 
 
59 60 IIA T1N1M0 Squam No -- 2 
7 
 
79 65 I T1N0M0 Squam No -- -- 
8 
 
59 60 IIA T1N1M0 Squam No -- 2 
9 
 
78 65 IB T2N0M0 Squam Yes 10 -- 
10 
 
73 68 I T1N0M0 Squam No -- -- 
11 
 
81 50 I T1N0M0 Small No -- 1 
12 
 
89 63.5 I T1N0M0 Adeno No 40 -- 
13 
 
78 65 IB T2N0M0 Squam Concurrent 10 -- 
14 
 
77 63.5 IV T2NXM1 Adeno No -- 13 
15 
 
59 68 IIB T1N1M0 Squam Concurrent -- -- 
16 
 
70 64 IB T2N0M0 Adeno No 11 -- 
17 
 
59 70 IV T3N0M1 Squam Induction 7 -- 
18 
 
59 74 IIIB T3N0M0 Squam Concurrent 23 -- 
19 
 
76 60 I T1N0M0 Squam No - 76 
20 
 
73 60 IB T2N0M0 Unknown No 3 -- 
21 
 
78 63.5 I T1N0M0 Adeno No -- -- 
22 
 
Unknown Unknown Unknown Unknown Unknown Unknown -- -- 
23 
 
51 58 IIIB T3N0M0 Unknown None --- 5 
24 
 
85 60 IIIA --- Large Cell --- -- -- 
25 
 
68 60 IIIB --- Adeno --- -- -- 
26 
 
67 60 IIIB --- Squam --- --- --- 
27 
 
76 60 IIIA --- Squam --- -- -- 
28 
 
60 60 IIIA --- Adeno --- -- -- 
29 
 
76 60 IIIB --- Large cell --- --- --- 
30 
 
70 60 IIIB --- Adeno --- -- -- 
31 
 
45 50 IV --- Adeno --- -- -- 
32 
 
60 60 IV --- Squam --- --- --- 
33 
 
76 63 IIIB --- Squam --- -- -- 
34 
 
71 64 IIIA --- Adeno --- -- -- 
35 
 
70 60 IIIA --- Squam --- --- --- 
36 
 
70 60 IIIA --- Large cell --- -- -- 
37 
 
71 60 IIIA --- Large cell --- -- -- 
38 
 
77 60 IIIA --- Large cell --- --- --- 
39 
 
77 50 IIIB --- Adeno --- -- -- 
40 
 
76 62 IIIA --- Squam --- -- -- 
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The Following are the same patients 
   Lesions 1 & 2   
   Lesions 7 & 9   
   Lesions 10 & 14   
 
Table A-II.  Predicted Volumes for Last Fraction 
Lesion 
Initial       
Volume 
(cc) 
Actual 
Final 
Volume 
(cc) 
Percent 
Change in 
Mass (%) 
Percent 
Change in 
Volume 
(%) 
Predicted 
Final 
Volume (cc) 
Error 
between 
Predicted and 
Actual (cc) 
± 95% 
Confidence 
Interval (cc) 
1 1.90 1.80 -24% -5% 1.9 0.1 1.0 
2 2.10 0.90 -69% -57% 0.8 0.1 0.2 
3 3.20 1.90 -86% -41% 1.9 0.0 0.3 
4 4.80 1.00 -- -79% 1.2 0.2 0.6 
5 5.70 3.70 -- -35% 4.0 0.3 0.8 
6 5.90 3.90 -25% -34% 4.2 0.3 0.5 
7 8.10 1.90 -- -77% 1.4 0.5 0.2 
8 8.90 2.40 -91% -73% 2.2 0.2 0.3 
9 13.20 2.80 -57% -79% 3.4 0.6 0.6 
10 13.70 8.90 -- -35% 9.8 0.9 1.0 
11 18.30 8.20 -42% -55% 7.7 0.5 0.6 
12 19.10 7.80 -63% -59% 8.6 0.8 1.3 
13 21.30 11.60 -76% -46% 12.1 0.5 3.3 
14 21.70 11.00 -54% -49% 11.8 0.8 0.9 
15 21.90 7.30 -- -67% 7.7 0.4 0.6 
16 22.60 7.30 -- -68% 8.3 1.0 1.0 
17 23.50 15.90 -46% -32% 15.7 0.2 2.3 
18 24.70 2.80 -65% -89% 2.2 0.6 1.1 
19 32.60 14.30 -75% -56% 15.2 0.9 0.6 
20 33.50 13.10 -68% -61% 13.5 0.4 0.8 
21 33.80 12.40 -35% -63% 11.4 1.0 1.5 
22 35.73 27.46 -- -23% 28.9 1.5 1.7 
23 37.55 31.74 -- -15% 32.1 0.4 1.6 
24 41.20 23.90 -- -42% 25.2 1.3 1.6 
25 50.50 31.00 -- -39% 31.9 0.9 0.6 
26 65.04 57.26 -- -12% 53.5 3.8 8.0 
27 65.90 20.00 -- -70% 21.1 1.1 2.0 
28 99.90 33.50 -- -66% 31.8 1.7 1.7 
29 104.70 75.20 -- -28% 70.0 5.2 6.0 
30 108.43 64.02 -- -41% 64.9 0.9 2.7 
31 115.30 89.70 -- -22% 83.8 5.9 6.8 
32 132.30 90.30 -- -32% 92.1 1.8 3.1 
33 155.80 74.60 -- -52% 76.0 1.4 2.3 
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 Table A-II.  Predicted Volumes for Last Fraction (continued) 
 
Lesion 
Initial       
Volume 
(cc) 
Actual 
Final 
Volume 
(cc) 
Percent 
Change in 
Mass (%) 
Percent 
Change in 
Volume 
(%) 
Predicted 
Final 
Volume (cc) 
Error 
between 
Predicted and 
Actual (cc) 
± 95% 
Confidence 
Interval (cc) 
34 171.30 140.10 -- -18% 130.3 9.8 9.7 
35 173.50 108.40 -- -38% 112.9 4.5 1.1 
36 201.70 25.60 -- -87% 37.6 12.0 11.4 
37 250.00 138.80 -- -44% 145.4 6.6 8.1 
38 484.60 386.14 -- -20% 361.8 24.3 25.0 
39 735.80 397.00 -- -46% 354.4 42.6 44.7 
40 737.20 265.20 -- -64% 261.8 3.4 15.9 
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APPENDIX B.  MATLAB CODE 
 
function [rms ypred yact] = lungcom(x, h_KR) 
l=[1:20]; %days used for observation (remember that l=1 goes w/ day=0) 
for i=1:size(x,2) %iterate through patients using other patients to predict 
for B=1:50 % start bootstrap for uncertainty 
g = sort(randsample(l,size(l,2),1)); %get bootstrap samples 
[row, col]=size(x(g,:));  
yact=x(66,:); %row 66 has the final volume for each patient at the end of 
their treatment 
h_KR=3.5; %found h_KR using LVOCV 
a=[1:col]; %used to set difference 
V=diag(ones(20,1)); %for variance 
b=setdiff(a,i); %set difference to get vector of all patients except the one 
that is being predicted 
[ys,ym,yst]=zscore(x); %scale the data 
XT=ys(g,b); %set x-training data 
XQ=ys(g,i); %set x-query data 
YT=ys(66,b); %set y-testing data 
YQ=ys(66,i); %set y-query data 
p=1;   
[YHAT1] = lwr_mm(XT',YT',h_KR,XQ'); %predict final volume 
ypred(B,i)=unscore(YHAT1, ym(i), yst(i)); %unscale the predicting 
end 
end 
rms=mean(abs(mean(ypred)-yact)); 
end 
 
function [yq unc] = lwpr1_mm_local(X,Y,sc,q, noisevar)  
% 
%   Locally Weighted Polynomial Regression with Local Gaussian kernal and 
Euclidean distance. 
%   Multivariate input matrix. 
% 
% X     - input data matrix 19X10 
% Y     - output data matrix 
% sc    - bandwidth vector 
% q     - matrix of query vectors: row = observation, column = inputs 
% yq     - prediction for q 
  
% Hines 2002 
% University of Tennessee 
X=[X X.^2]; % compute squares of inputs 
q=[q q.^2]; 
%[X xm xs]=zscore1(X); 
%q=zscore1(q,xm,xs); 
  
[n,nx] = size(X);           % n is number of patterns 
[n,ny] = size(Y);         % nx and ny are number of inputs  
                            % and outputs 
                             
iters=size(q,1); 
yq=zeros(1,iters); 
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%h = waitbar(0,'Please wait...'); 
  
Xq=X;                       % Original Inputs 
X = [X ones(n,1)];          % Inputs appended with ones for intercept 
nx = nx+1;                  % New number of inputs 
scn=[sc sc.^2]; 
scn=[scn 1]; 
for i=1:iters; 
     q1 = [q(i,:) 1]; % Query appended with ones 
     B=repmat(q1,size(X,1),1); 
     d=abs(X-B)';   % Distance metric 
      %scc=repmat(scn,size(Xq,2), 1); 
     scc=repmat(sc,size(X,2), 1); 
     w=exp(-sqrt(sum((d.^2)./scc.^2)));         %Gaussian Kernal function 
     wX = X.*(w'*ones(1,nx));                % Weighted inputs 
     yq(i) = q1*pinv(wX'*X)*wX'*Y; 
     unc(i)=w*w'*noisevar; 
     %  scc=repmat(sc,size(Xq,1), 1); 
%     w=exp(-(d.^2)/sc.^2);         % Gaussian Kernal function 
%     wX = X.*(w*ones(1,nx));     % Weighted inputs 
 %   waitbar(i/iters,h) 
end     
%close(h) 
 
 
load('lungcom'); 
l=[1, 2, 3, 6, 9, 10, 12, 18]; 
[row, col]=size(y(l,:)); 
for i=8:11; 
q=isnan(s(:,i)); 
u=find(q==0); 
z=find(u>20); 
ytry=u(z); 
h_KR=3.5; 
a=[1:col]; 
V=diag(ones(20,1)); 
for j=1:size(ytry) 
    b=setdiff(a,i); 
    [ys,ym,yst]=zscore(y'); 
    XT=ys(b,l); 
    XQ=ys(i,l); 
    YT=ys(b,ytry(j)); 
    YQ=ys(i,ytry(j)); 
    p=1;   
    [YHAT1, Var_KR4] = lwr_mm(XT,YT,h_KR,XQ); 
    ypred(j,i)=unscore(YHAT1, ym(ytry(j)), yst(ytry(j))); 
    Var_kr(j,i)=Var_KR4; 
    Var_lwr(j,i)=unscore(Var_KR4, ym(ytry(j)), yst(ytry(j))); 
    yact=y(ytry(j),i); 
    prederror(j,i)=abs(ypred(j)-yact); 
    predper(j,i)=((abs(yact-ypred(j)))./yact).*100; 
    
end 
figure 
o=union(l,u); 
ytrue=y(o,i); 
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siztrue=size(ytrue); 
g=y(l,i); 
nonzp=nonzeros(ypred(:,i)); 
ytest=[g; nonzp]; 
tr=union(l, ytry); 
nonzv=nonzeros(Var_lwr(:,i)); 
CI=2*sqrt(nonzv); 
hold on 
plot(tr-1, ytest, 'k*:') 
hold on 
plot(o-1, ytrue, 'b.--') 
errorbar(ytry-1, nonzp, CI, 'r+'); 
legend('Predicted', 'Actual', '95% Confidence Interval'); 
xlabel('Elapsed Days'); 
ylabel('Volume (cc)'); 
title(['Patient ' num2str(i) ]) 
end 
 
function [mse ypred yact unc traindat realactpreddat realpreddat YQ] = 
lunggetgraph(org, x, sc, gax, nodays, novar) 
[row col]=size(x); 
[row col]=size(x); 
days=sort(unique(round(gax(1:nodays)))); %days used for observation (remember 
that l=1 goes w/ day=0) 
ypred=zeros(row,1); 
h_KR=gax(nodays+1:col+nodays); 
traindat=zeros(row,1); 
unc=zeros(row,1); 
yact=zeros(row,1); 
i=17; %iterate through patients using other patients to predict 
a=[1:col]; %used to set difference 
b=setdiff(a,i); %set difference to get vector of all patients except the one 
that is being predicted 
k=find(isnan(org(:,i))==0); 
[trainday]=find(k<20); 
[testday]=find(k>20); 
testdat=k(testday); 
    for m=1:(size(testdat)-1) 
    b=setdiff(a,i); %set difference to get vector of all patients except the 
one that is being predicted 
    XT=x([days],b); %set x-training data 
    XQ=x([days],i); %set x-query data 
    YT=x(testdat(m),b); %set y-training data 
    YQ(m)=x(testdat(m),i); %set y-query data 
    yact(testdat(m))=x(testdat(m),i); %row 65 has the final volume for each 
patient at the end of their treatment 
    localsc=h_KR(b); 
    [ypred(testdat(m)) unc(testdat(m))] = lwpr1_mm_local(XT',YT',localsc, 
XQ', novar); %predict final volume 
    end 
  
  
    realactpreddat=yact.*sc(1,i); 
    realpreddat=ypred.*sc(1,i); 
    realunc=sqrt(unc.*sc(1,i)); 
[I J]=find(realpreddat~=0); 
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for t=1:size(I) 
    error(t)=abs(realpreddat(I(t), J(t))-realactpreddat(I(t), J(t))); 
end 
figure 
plot(k(1:size(k,1)-1),org(k(1:size(k,1)-1),i),'b.') 
hold on 
plot(x(1:testdat(m),i).*sc(1,i), 'b') 
hold on 
plot(days, x(days,i).*sc(1,i), 'mo') 
errorbar(testdat(1:m), realpreddat(testdat(1:m)), realunc(testdat(1:m)), 'r') 
for t=1:size(I) 
    error(t)=abs(realpreddat(I(t), J(t))-realactpreddat(I(t), J(t))) 
end 
testdat 
mse=sum(error); 
  
end 
 
function [mse ypred yact unc] = lungscVollocalnopath(x, sc, gax, nodays, 
novar) 
[row col]=size(x); 
days=sort(round(gax(1:nodays))); %days used for observation (remember that 
l=1 goes w/ day=0) 
h_KR=gax(nodays+1:col+nodays); 
for i=1:size(x,2) %iterate through patients using other patients to predict 
yact(i)=x(65,i); %row 65 has the final volume for each patient at the end of 
their treatment 
a=[1:col]; %used to set difference 
b=setdiff(a,i); %set difference to get vector of all patients except the one 
that is being predicted 
XT=x([days],b); %set x-training data 
XQ=x([days],i); %set x-query data 
YT=x(65,b); %set y-testing data 
YQ=x(65,i); %set y-query data 
localsc=h_KR(b); 
p=1;   
[ypred(i) unc(i)] = lwpr1_mm_local(XT',YT',localsc, XQ', novar); %predict 
final volume 
end 
mse=100*mean(abs(yact(1:col)-ypred(1:col)))+mean(abs(yact(1:col).*sc(1:col)-
ypred(1:col).*sc(1:col))); 
  
% prederror(B,:)=abs(ypred(B,:)-yact); 
% predper(B,:)=((abs(yact-ypred(B,:)))./yact).*100; 
    
end 
 
function [mse ypred yact unc] = lungscmasslocalnopath(x, sc, gax, novar) 
[row col]=size(x); 
days=[1 2 3 4 7 8 9 10 11 12 13 14 15 16 17 19 20]; %days used for 
observation (remember that l=1 goes w/ day=0) 
h_KR=gax(1:col); 
for i=1:size(x,2) %iterate through patients using other patients to predict 
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yact(i)=x(65,i); %row 65 has the final volume for each patient at the end of 
their treatment 
a=[1:col]; %used to set difference 
b=setdiff(a,i); %set difference to get vector of all patients except the one 
that is being predicted 
XT=x([days],b); %set x-training data 
XQ=x([days],i); %set x-query data 
YT=x(65,b); %set y-testing data 
YQ=x(65,i); %set y-query data 
localsc=h_KR(b); 
p=1;   
[ypred(i) unc(i)] = lwpr1_mm_local(XT',YT',localsc, XQ', novar); %predict 
final volume 
end 
mse=80*mean(abs(yact(1:col)-ypred(1:col)))+(mean(abs(yact(1:col).*sc(1:col)-
ypred(1:col).*sc(1:col)))); 
  
% prederror(B,:)=abs(ypred(B,:)-yact); 
% predper(B,:)=((abs(yact-ypred(B,:)))./yact).*100; 
    
end 
 
function [yq unc] = lwpr1_mm_local(X,Y,sc,q, noisevar)  
% 
%   Locally Weighted Polynomial Regression with Local Gaussian kernal and 
Euclidean distance. 
%   Multivariate input matrix. 
% 
% X     - input data matrix 19X10 
% Y     - output data matrix 
% sc    - bandwidth vector 
% q     - matrix of query vectors: row = observation, column = inputs 
% 
% yq     - prediction for q 
  
% Hines 2002 
% University of Tennessee 
X=[X X.^2]; % compute squares of inputs 
q=[q q.^2]; 
%[X xm xs]=zscore1(X); 
%q=zscore1(q,xm,xs); 
  
[n,nx] = size(X);           % n is number of patterns 
[n,ny] = size(Y);         % nx and ny are number of inputs  
                            % and outputs 
                             
iters=size(q,1); 
yq=zeros(1,iters); 
%h = waitbar(0,'Please wait...'); 
  
Xq=X;                       % Original Inputs 
X = [X ones(n,1)];          % Inputs appended with ones for intercept 
nx = nx+1;                  % New number of inputs 
scn=[sc sc.^2]; 
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scn=[scn 1]; 
for i=1:iters; 
     q1 = [q(i,:) 1]; % Query appended with ones 
     B=repmat(q1,size(X,1),1); 
     d=abs(X-B)';   % Distance metric 
      %scc=repmat(scn,size(Xq,2), 1); 
     scc=repmat(sc,size(X,2), 1); 
     w=exp(-sqrt(sum((d.^2)./scc.^2)));         %Gaussian Kernal function 
     wX = X.*(w'*ones(1,nx));                % Weighted inputs 
     yq(i) = q1*pinv(wX'*X)*wX'*Y; 
     unc(i)=w*w'*noisevar; 
     %  scc=repmat(sc,size(Xq,1), 1); 
%     w=exp(-(d.^2)/sc.^2);         % Gaussian Kernal function 
%     wX = X.*(w*ones(1,nx));     % Weighted inputs 
 %   waitbar(i/iters,h) 
end     
%close(h) 
 
function [mse ypred yact unc] = lungscVolnoday(x, sc, gax, nodays, novar) 
[row col]=size(x); 
days=sort(unique(round(gax(1:nodays)))) %days used for observation (remember 
that l=1 goes w/ day=0) 
h_KR=gax(nodays+1:col+nodays); 
for i=1:size(x,2) %iterate through patients using other patients to predict 
yact(i)=x(65,i); %row 65 has the final volume for each patient at the end of 
their treatment 
a=[1:col]; %used to set difference 
b=setdiff(a,i); %set difference to get vector of all patients except the one 
that is being predicted 
XT=x([days],b); %set x-training data 
XQ=x([days],i); %set x-query data 
YT=x(65,b); %set y-testing data 
YQ=x(65,i); %set y-query data 
localsc=h_KR(b); 
p=1;   
[ypred(i) unc(i)] = lwpr1_mm_local(XT',YT',localsc, XQ', novar); %predict 
final volume 
end 
mse=100*mean(abs(yact(1:col)-ypred(1:col)))+mean(abs(yact(1:col).*sc(1:col)-
ypred(1:col).*sc(1:col))); 
  
% prederror(B,:)=abs(ypred(B,:)-yact); 
% predper(B,:)=((abs(yact-ypred(B,:)))./yact).*100; 
    
End 
 
 
function plotaakr(p, act, numst, numend, myavi) 
x=[1:1:size(p,1)]; 
count=0; 
close 
for i=numst:1:numend 
count=count+1 
plot(x,act(:,i),'.',x,p(:,i),'k','LineWidth',1.5); 
ylabel('Detector Count'); 
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xlabel('Detector Channel'); 
legend('Actual','Predicted','Location','Best'); 
frame = getframe(gca, [0 0 435 343]); 
myavi = addframe(myavi,frame); 
end 
end 
 
function [errormap, detecteders]=mlcerrordet(fwhmtable1, fwhmtable2, frames, 
threshold); 
for i=1:size(fwhmtable1,1) 
for j=1:size(fwhmtable1,2) 
if ((fwhmtable1(i,j)==0) | (fwhmtable2(i,j)==0)) 
errormap(i,j)=0; 
else 
errormap(i,j)=((fwhmtable1(i,j)/frames)-(fwhmtable2(i,j)/frames))*100; 
end 
end 
end 
  
[r c]=find(abs(errormap)>threshold); 
k=unique(r); 
count=1; 
for i=1:size(k) 
t=find(r==k(i)); 
if size(t)==1; 
newerror(count)=k(i); 
count=count+1; 
end 
end 
  
j=[r c]; 
for k=1:size(newerror,2) 
l=find(r==newerror(k)); 
newj(k,:)=j(l,:); 
end 
  
detecteders=unique(newj, 'rows'); 
  
end 
 
 
function [meanmse yq ya yact yt] = lunglpr(x,y,nodays) 
days=sort(round(x(1:nodays))) 
[nox1, nox2]=size(x); 
k=x(nodays+1:nox2); %h_kr 
clear ypred 
clear sc 
gd=[days, 59]; 
[ys,ym,yst]=zscore(y(gd,:)'); 
xdat=ys(:,1:nodays); 
ydat=ys(:,nodays+1); 
for i=1:20 
     %row 59 has the final volume for each patient at the end of their 
treatment 
    a=[1:size(y,2)]; %used to set difference 
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    b=setdiff(a,i); %set difference to get vector of all patients except the 
one that is being predicted 
    sc=k(b); 
    XT=xdat(b,:); 
    YT=ydat(b,:); 
    XQ=xdat(i,:); 
    yq(i) = lwpr1_mm_local(XT,YT,sc,XQ); 
%     yp(i)=lwpr_mm(XT,YT,3,XQ); 
%     yl(i)=lwr_mm(XT,YT,3,XQ); 
   yact(i)=ys(i, nodays+1); 
   yt(i)=unscore(yq(i), ym(nodays+1), yst(nodays+1)); 
%     yc(i)=unscore(yp(i), ym, ystd); 
%     yv(i)=unscore(yl(i), ym, ystd); 
     ya(i)=unscore(yact(i), ym(nodays+1), yst(nodays+1)); 
end 
meanmse=(sumsqr(yt-ya))/length(ya) 
 
 
i=setdiff(1:20, 3); 
for j=1:size(i,2);   
fid = fopen(['F:\MatLab Sinogram Data\Prostate Test\       ', num2str(i(j)), 
'.sin']); 
if fid==-1 
    fid = fopen(['F:\MatLab Sinogram Data\Prostate Test\      ', 
num2str(i(j)), '.sin']); 
end 
if fid~=-1 
sinogram(j).data=fread(fid, [643 757], 'float'); 
sinogram(j).trial=i(j); 
keeptrack(j)=i(j); 
end 
end 
count=0 
for b=1:size(i,2)-1   
    for k=b+1:size(i,2)      
        count=count+1 
        sinogram(count).subtraction=sinogram(i).data(38:597,:)-
sinogram(j).data(38:597,:); 
        sinogram(count).subtractkeeptrack=[i,j]; 
    end 
end 
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APPENDIX C. AAKR DETECTION OF SINOGRAM ERRORS 
This appendix presents more figures of the AAKR model detecting MLC positional errors.  The 
model predictions for the unmodified projections which are prequel to the faulted projection are 
also shown to help illustrate how the model responds under normal operating conditions.  In all 
of the figures the blue dots are the measured detector counts and the black lines are the AAKR 
predictions. 
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LUNG DELIVERY AAKR PREDICTIONS 
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PROSTATE DELIVERY AAKR PREDICTIONS 
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